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ABSTRACT 
 
 Autosomal dominant polycystic kidney disease (ADPKD) is the most 
common monogenic disease, and is characterized by multiple fluid-filled cysts that 
impair the organ, ultimately leading to renal failure.  Formation and enlargement of 
the cysts require abnormal proliferation and cell death, as well as changes in the 
transport properties of the renal tubule epithelial cells.  Because of its primary role in 
the vectorial movement of salt and water in the kidney, the Na,K-ATPase has been 
the focus of investigation to understand the pathophysiology of ADPKD.  However, 
the precise role of the transporter has not been identified.  In this dissertation, we 
describe studies designed to characterize the Na,K-ATPase in ADPKD, and examine 
the mechanisms underlying its role in the disease. 
 The transport properties of the Na,K-ATPase is regulated by the hormone 
ouabain, which inhibits its movement of the cations.  In addition, ouabain binding to 
the Na,K-ATPase has been been found to activate a cascade of phosphorylating 
events, leading to cell growth.  Interestingly, we have found a population of the Na,K-
ATPase in human cystic epithelial cells to have a higher affinity for ouabain, at 
concentrations consistent with circulating levels of the hormone.  Thus, nanomolar 
concentrations of ouabain that do not normally affect the activity of the Na,K-ATPase 
in the kidney partially inhibit the enzyme of cystic tissue and cells.  The Na,K-
ATPase has been found to interact with polycystin-1, and we have found this to 
association to increase the sensitivity of the enzyme to ouabain. 
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 Our hypothesis is that due to their increased sensitivity to the hormone in 
ADPKD, the cystic renal epithelium is more susceptible to the effects of endogenous 
ouabain.  We found ouabain to stimulate both proliferation and apoptotic death of the 
ADPKD cells, causing a disbalance that favors increased cell growth.  While the 
mitogenic effect of ouabain is mediated by activation of the epidermal growth factor 
receptor (EGFR), Src kinase and extracellular signal-regulated kinase (ERK) 
pathway, its apoptotic effect was found to be through activation of the intrinsic 
pathway of apoptotic cell death.  We also found ouabain to exacerbate the 
development and growth of cysts, both in cultured human ADPKD cells and 
metanephric organ cultures from Pkd1m1Bei mice, a well characterized model of 
ADPKD.  Collectively, these results demonstrate ouabain, acting through the Na,K-
ATPase, is a novel agent that can adversely affect the progression of ADPKD. 
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CHAPTER 1 
INTRODUCTION 
Na,K-ATPase 
 The Na,K-ATPase or Na pump is a plasma membrane enzyme that 
establishes and maintains the high external Na+ and high intracellular K+ 
concentrations typical of most animal cells [1].  By using the energy from the 
hydrolysis of ATP, it transports 3 Na+ out in exchange for 2 K+ that are taken into 
the cell [2, 3]. The Na,K-ATPase plays a key role in numerous cell processes that 
depend directly or indirectly on the transmembrane gradients of Na+ and K+.  In this 
manner, the enzyme is essential in maintaining cell osmotic balance, volume and 
pH, in maintaining the cell resting membrane potential, and in creating the inward 
gradient of Na+ that provides the chemical energy for the secondary Na+-coupled 
transport of other ions, solutes, and water across the cell membrane [1, 4, 5]. In the 
kidney, the adequate function of the Na,K-ATPase at the basolateral membrane of 
the tubular epithelial cells is essential for reabsorption of Na+ and water [1]. 
 Structurally, the Na,K-ATPase consists of distinct molecular forms of two 
main polypeptides, the α and β subunits [6, 7]. The α polypeptides constitute the 
catalytic subunit of the Na,K-ATPase, directly participating in the ion transport and 
catalytic activity of the enzyme [6].  The α isoforms are ten membrane-spanning 
proteins that contain the binding sites for Na+, K+ and ATP.  In addition, the α 
isoforms bind cardenolides, such as ouabain [2]. The β subunits are single 
membrane spanning glycoproteins that are important during synthesis of the Na,K-
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ATPase, controlling the proper folding and trafficking of the α subunit to the 
plasma membrane [8-10]. An interesting characteristic of the Na,K-ATPase is its 
molecular heterogeneity. Four structural variants of the α (α1, α2, α3 and α4) and 
three different β (β1, β2 and β3) isoforms that are the product of different genes 
have been discovered in mammalian tissues [11-13].  Association of the various α 
and β polypeptides in different heterodimers gives rise to multiple Na,K-ATPase 
isozymes, each of which exhibit a particular tissue localization and unique 
functional characteristics [13-17]. The α1 isoform is expressed in almost every cell, 
while the other α polypeptides show a tissue specific pattern of expression [13].  
The α2 isoform predominates in adipocytes, muscle, heart  and brain  [18-24], α3 is 
abundant in nervous tissues [22, 24, 25], and the α4 isoform is a sperm-specific 
isoform [26].  Also, the β isoforms are distributed in a tissue-dependent manner. 
The β1 polypeptide is widely distributed [13], β2 is found in skeletal muscle, pineal 
gland and nervous tissues [27, 28], while β3 is expressed in testis, retina, liver and 
lung [29]. The pattern of Na,K-ATPase isoform expression is subjected to 
developmental as well as hormonal regulation and can be altered during disease [13, 
30, 31].  Na,K-ATPase isozymes composed of different α isoforms have unique 
kinetic properties reflected by their differential affinities for the transported ions, 
Na+ and K+, the substrate, ATP, and ouabain.   
 Also, the activity of the various Na,K-ATPases exhibit a distinctive 
response to a series of physiological stimuli, such as hormones and autacoids. The 
differences in expression, activity and regulation of the Na,K-ATPase isoforms 
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appear to be essential in adapting cellular Na,K-ATPase activity to the specific 
physiological requirements of each cell. Current information suggests that the α1β1 
isozyme functions as the housekeeping Na,K-ATPase maintaining the basic Na+ 
and K+ homeostasis in the cell, whereas the other isozymes mediate tissue-specific 
roles.  Importantly, the α1β1 heterodimer constitutes the only Na,K-ATPase present 
in normal kidney and may be the isozyme primarily suited for salt and water 
transport in this organ [1, 13]. 
 
Na,K-ATPase as a signal transducer of ouabain effects 
 Several transport molecules have been shown to associate with an array of 
proteins, including kinases and phosphatases, cytoskeletal tethers and adaptor 
proteins to form regulatory complexes in the cell. Some of these protein complexes 
are involved in signal transduction events that extend beyond the plasma membrane 
to transmit signals into the cell [32].  Interestingly, a role in signal transduction has 
also been reported for the Na,K-ATPase [33-37]. The Na,K-ATPase is the natural 
receptor for cardenolides, a family of steroidal substances that share the unique 
property of binding to the external surface of the α subunit of the Na,K-ATPase [6, 
7]. One of the most common cardenolides, extensively used as a tool to specifically 
define Na,K-ATPase activity in a sample, is ouabain. At high millimolar 
concentrations, ouabain has a toxic effect, inhibiting the cycling, transport and 
catalytic activity of the total Na,K-ATPase in the cell [2, 3]. In contrast, low 
ouabain concentrations (in the nanomolar range), exerts other effects that are 
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independent from the inhibition of the ion transport function of the Na,K-ATPase. 
In several cell types, ouabain-Na,K-ATPase binding triggers a cascade of cell 
events that include interaction of the enzyme at the plasma membrane with 
neighboring proteins and the activation of the tyrosine kinase Src [38, 39]. This 
subsequently causes the recruitment and phosphorylation of a series of proteins 
including the mitogen activated protein kinases (MAPK), the extracellular regulated 
kinase, ERK pathway, and serine and tyrosine protein kinases [40]. The process 
ultimately results in regulation of several cell processes, including cell motility and 
growth [34, 41, 42].  
 For many years, ouabain was thought to be strictly a product of plants.  
However, the compound was more recently discovered as an endogenous substance 
present in nanomolar amounts in the fluids of several mammals, including man [41, 
43-46]. Ouabain is synthesized in the adrenal glands and is released to the 
circulation by several stimuli, such as increase Na+ levels, hypoxia and physical 
exercise [42, 45]. In addition, elevated levels of ouabain have been found under a 
number of conditions, such as chronic renal failure, hyperaldosteronism and 
preeclampsia [42].   
 
Na,K-ATPase regulation 
 Due to the central role of the Na,K-ATPase in fluid movement across the 
renal epithelium, the enzyme is subjected to strict regulatory mechanisms. These 
mechanisms act at different levels to produce both acute and chronic changes in 
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Na,K-ATPase activity. Long-term regulation of Na,K-ATPase function depends on 
changes in the transporter expression at the cell plasma membrane through changes 
in the rate of synthesis/degradation or redistribution with intracellular stores [13, 
47]. Short-term regulation of Na,K-ATPase is achieved through direct modification 
of the activity of the enzyme [13]. This is caused by interaction of the enzyme with 
several ligands, mainly ions, such as Na+ and Ca+2.  In addition, another important 
mechanism to regulate Na,K-ATPase transport function is interaction with other 
proteins [13].  Use of the yeast two-hybrid system and co-immunoprecipitation 
assays have identified a series of proteins that associate with the Na,K-ATPase.  
Interestingly, among these proteins is polycystin-1 (PC-1), one of the polypeptides 
known to be altered in polycystic kidney disease. 
 
ADPKD as a disease 
 ADPKD is one of the most common, potentially lethal inherited disorders, 
with a prevalence of 1 in 500 to 1,000 births nationwide. ADPKD afflicts more 
individuals than cystic fibrosis, sickle cell anemia, hemophilia, muscular dystrophy, 
Down’s syndrome and Huntington’s disease combined. Although ADPKD is a 
systemic disorder with multiple manifestations, including hypertension, renal 
stones, and extrarenal cysts in the pancreas, liver and intestines, its most prominent 
feature is the formation of numerous fluid-filled cysts that originate from the 
epithelial cells within all nephron segments. Progressive expansion of the cysts 
causes a 4-8 fold enlargement of the kidney that grossly distorts the structure of the 
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renal parenchyma and reduces its function. Approximately one half of ADPKD 
patients progress to chronic renal failure and require dialysis or kidney replacement 
by the age of 60, and ADPKD is responsible for approximately 8-10% of all cases 
of end-stage renal  failure [48-51]. End stage renal disease caused by polycystic 
kidney disease (PKD) alone costs the federal government more than $2 billion per 
year in Medicare and Medicaid costs. The burden caused by ADPKD and its 
economic costs fuels the need to understand the molecular basis of the disease to 
find appropriate interventional therapies that can slow or stop its progression.   
 
Etiology of ADPKD 
 ADPKD is caused by mutations in the Pkd1 and Pkd2 genes, which encode 
for polycystin-1 (PC-1) and 2 (PC-2) respectively [50, 52]. PC-1 is a 450,000-
460,000 kDa glycoprotein composed of a large extracellular region that has 
adhesion and protein-protein interaction domains, 11 transmembrane spanning 
domains, and a short C-terminal portion involved in cell signaling[53, 54]. On the 
other hand, PC-2 is a 6-membrane spanning protein that appears to function as a 
Ca+2 permeable non-selective cation channel [55].  Although the precise functions 
of PC-1 and PC-2 are not known, current evidence suggests that PC-1 and PC-2 
interact to form a macromolecular signaling system that acts as a mechanosensor 
capable of receiving extracellular signals and transducing them into cellular 
responses that regulate fundamental aspects of renal epithelial development and cell 
biology [55]. Mutations in PC-1 and PC-2, or an imbalance in expression of either 
  7
protein results in deregulation of signaling pathways that are important for the 
control of renal epithelial proliferation, migration, differentiation and nephron 
tubular morphogenesis [48, 56].  
In addition to the genetic causes of ADPKD, non-genetic factors such as 
pharmacological agents and compounds circulating in blood play an important role 
in influencing the rates of cell proliferation and fluid secretion by the renal 
epithelium, contributing to the development and progression of renal cysts [57-60]. 
The role of non-genetic factors explains in part the high degree of variability in the 
age of onset and progression of the disease, even among family members that carry 
the same mutation. 
 
ADPKD and renal cystogenesis  
Studies in humans and a variety of experimental models of PKD implicate 
several major factors in the formation and maintenance of renal cysts. One is the 
abnormal proliferation or hyperplasia of the tubular cells; the second is the change 
in the salt and fluid transport properties of the epithelium, which modifies its 
reabsorptive capacity to favor secretion of fluid into the lumen of the vesicles [60, 
61]. The first event in cystogenesis appears to be the uncontrolled cell growth, with 
the subsequent expansion of the tubular renal epithelium that constitutes “blister 
like” structures. These structures eventually pinch off and lose contact with the 
parent nephron from which they originated. Cysts then continue to develop, 
increasing their size through the combined effect of proliferation of the cells 
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surrounding the cyst, and the continuous secretion of fluid by the epithelium that 
accumulates and enlarges the cyst cavity [62, 63]. Agents such as cAMP, steroids 
and epidermal growth factor (EGF) have been shown to alter growth as well as ion 
and water transport in ADPKD [58, 59, 64-66].  
  In addition to abnormal cell proliferation and fluid transport, apoptotic cell 
death has been shown to be dysregulated in PKD.  Apoptosis involves a complex 
and highly regulated process of programmed cell death that is important during 
normal embryonic development and maintenance of normal adult tissues [67].  Both 
proliferation and apoptosis have been reported to be up-regulated in the cystic 
epithelium [51], and inhibition of apoptosis has been shown to slow development of 
the disease [68].  This suggests that an imbalance in proliferation and apoptosis may 
promote cystogenesis and progression of PKD.   
At present, the precise mechanisms that cause the changes in cell growth 
and fluid transport characteristic of ADPKD are unknown.  Although the genetic 
factor is important, it remains unclear how it contributes to the pathophysiology of 
the disease.  Several circulating agents have been identified to have a crucial role in 
progression of ADPKD.  Understanding the factors and mechanism(s) involved in 
formation and maintenance of renal cysts in ADPKD is essential in predicting the 
outcome of the disease, as well as identifying targets for future development of 
pharmacological approaches to treat this illness. 
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Specific aims of this work 
 The major objective of this study was to determine the role of the Na,K-
ATPase in ADPKD.  Previous results from our laboratory have shown that the 
Na,K-ATPase of animal models of PKD, such as the Han:SPRD cy/cy rat and cpk 
mouse, has an abnormally high affinity for ouabain.  Therefore, it is possible that 
this will render the renal epithelial cells more susceptible to the effect of the 
hormone ouabain.  The overall hypothesis motivating this work is the high ouabain-
sensitive phenotype causes ADPKD cells to be more prone to the effects of 
circulating levels of the hormone; endogenous ouabain excessively stimulates 
Na,K-ATPase signaling to cause hyperplasic growth and fluid secretion by the renal 
epithelium.  We reasoned that ouabain represents a novel factor capable of 
exacerbating the development of ADPKD renal cysts, thus contributing to the 
progression of the disease. 
 The following specific aims were directed to elucidate our hypothesis: 
1. Determine the role of ouabain/Na,K-ATPase signaling in proliferation of 
human renal epithelial cells from patients with ADPKD (Chapter 2). 
2. Identify the signaling pathway involved in the ouabain-induced proliferation 
of ADPKD cells (Chapter 3). 
3. Examine the effects of ouabain on apoptosis of ADPKD cells (Chapter 4). 
4. Assess the influence of ouabain on fluid secretion by the ADPKD 
epithelium (Chapter 5). 
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5. Establish the role of PC-1 in modulating the ouabain affinity and signaling 
function of the Na,K-ATPase (Chapter 6). 
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 CHAPTER 2 
OUABAIN INDUCES PROLIFERATION IN ADPKD CELLS 
ABSTRACT 
 In autosomal dominant polycystic kidney disease (ADPKD) cyst formation 
and enlargement requires proliferation of mural renal epithelial cells and the 
transepithelial secretion of fluid into the cyst cavity. Na,K-ATPase is essential for 
solute and water transport in ADPKD cells, and ouabain blocks fluid secretion in 
these cells.  By binding to the Na,K-ATPase, ouabain also induces proliferation in 
some cell types.  Surprisingly, we found that nanomolar concentrations of ouabain, 
similar to those circulating in blood, induced ADPKD cell proliferation, but had no 
statistically significant effect on normal human kidney cells (NHK).  Ouabain, acting 
from the basolateral side of the cells, also caused an increase in the level of 
phosphorylated extracellular regulated kinases (ERK).  MEK inhibitor U0126 
blocked ouabain-induced ERK activation and cell proliferation, suggesting that the 
effect of ouabain is mediated through the MEK-ERK pathway.  In contrast to NHK 
cells, the dose response curve for ouabain inhibition of Na,K-ATPase activity 
indicated that approximately 20% of the enzyme in ADPKD cells exhibits a higher 
affinity for ouabain.  The increased ouabain affinity of ADPKD cells was not due to 
differences in Na,K-ATPase isoform expression since these cells, like NHK cells, 
only possess the α1 and β1 subunits.  The γ variants of the Na,K-ATPase are also 
expressed in the cells, but are elevated in ADPKD cells.  Currently, the basis for the 
differences in ouabain sensitivity of NHK and ADPKD cells is unknown.  We 
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conclude that ouabain stimulates proliferation in ADPKD cells by binding to the 
Na,K-ATPase with high affinity, and via activation of  the MEK-ERK pathway.  
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INTRODUCTION 
 The Na,K-ATPase is an enzyme of the plasma membrane of most cells that 
uses cellular ATP to exchange cytoplasmic Na+ for extracellular K+[1].  The function 
of the Na,K-ATPase is essential for the generation and maintenance of the 
electrochemical gradients that drive the secondary movement of solute and fluid 
across renal epithelia [2].  Structurally, the Na,K-ATPase is an oligomer composed of 
distinct molecular forms of two major polypeptides, the α and β subunits [3].  At 
present, four structural variants of the α polypeptide (α1, α2, α3 and α4), and three β 
(β1, β2 and β3) subunits have been identified in mammals.  Association of the α and 
β polypeptides in different oligomers results in multiple isozymes of the Na,K-
ATPase that have unique functional properties, and a tissue-specific pattern of 
expression [3].  The α1 and β1 isoforms constitute the Na,K-ATPase isozyme 
ubiquitously expressed in tissues and the prevalent isozyme in kidney [2-4].  In 
addition to the α and the β subunits, the renal Na,K-ATPase contains a third subunit, 
the γ polypeptide that exists as two different splice variants, γa and γb [5]. 
 Cardiotonic steroids comprise a family of compounds that bind to the α 
subunit of the Na,K-ATPase to inhibit the function of the enzyme.  These compounds 
are clinically used to increase the force of heart contraction and cardiac output in 
patients with heart failure [6, 7].  Ouabain, a cardiotonic steroid has been shown to be 
an endogenous factor secreted by the adrenal glands in humans and other mammals, 
and is present in blood at nanomolar concentrations [8].  The mechanisms of action of 
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ouabain have been classically attributed to ion changes that are secondary to 
inhibition of the catalytic and transport activity of the Na,K-ATPase [6]. 
 More recently, it has been shown that ouabain also induces proliferation of 
several cell types, including myocardial cells, smooth muscle cells, astrocytes, and 
renal proximal tubule cells [9-14].  The mechanisms for the mitogenic effect of 
ouabain are not completely understood.  In myocardial cells, binding of ouabain to 
the Na,K-ATPase activates Src kinase and tyrosine phosphorylation of proteins 
including the epidermal growth factor receptor (EGFR).  Transactivation of EGFR 
then leads to a cascade of phosphorylating events that include the mitogen activated 
protein kinase kinase MEK and extracellular regulated kinases (ERK) [15].   
Activation of the MEK-ERK pathway results in expression of genes involved in cell 
growth [15]. 
 Autosomal dominant polycystic kidney disease (ADPKD) is characterized by 
the formation and progressive enlargement of cysts in the kidney that disrupt the 
structure and severely compromises renal function in about half of the patients [16, 
17].  In ADPKD, mutations of at least two genes, Pkd1 and Pkd2 that encode for 
polycystin 1 and 2 respectively, initiate cyst formation. However, the progressive 
enlargement of cysts appears to be regulated by a variety of factors, including growth 
hormones and cAMP agonists [18-20].  Arginine vasopressin (AVP) and epidermal 
growth factor (EGF) stimulate cell proliferation of human ADPKD cells through 
activation of the MEK-ERK pathway [21-24].  Cyclic AMP causes cell proliferation 
in human cells and animal models of polycystic kidney disease, also via the MEK-
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ERK pathway, through B-Raf, a kinase that phosphorylates and activates MEK [25, 
26].  In addition, cyst expansion is the result of transepithelial fluid secretion driven 
by the cAMP-dependent secretion of Cl- [27].  Because of its central role in salt and 
water transport, the Na,K-ATPase has been the focus of investigation to understand 
the pathophysiology of PKD [17].  Relatively high concentrations of ouabain added 
to basolateral, but not apical, membranes of ADPKD cell monolayers [28] and intact 
cysts dissected from ADPKD kidneys [24] have been shown to inhibit fluid secretion.  
However, the effect of low concentrations of ouabain, similar to those circulating in 
blood, on renal cyst growth has not been examined.  
 In the present study, we investigated the effect of physiological concentrations 
of ouabain on the growth and MEK-ERK pathway of cells derived from normal 
human kidneys and from renal cysts of patients with ADPKD.  This is the first report 
to demonstrate that human ADPKD cells present an abnormally high sensitivity to 
ouabain, and that the steroid stimulates proliferation of ADPKD cells at a higher rate 
than NHK cells via activation of the MEK-ERK pathway. 
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METHODS 
Cell culture 
Primary cell cultures derived from nephrectomy specimens of normal human 
kidney cortex (NHK cells) or surface cysts of ADPKD kidneys (ADPKD cells) were 
generated by the PKD Biomaterial Core at University of Kansas Medical Center 
(KUMC).  A protocol for the use of discarded human kidney tissues was approved by 
the Institutional Review Board at KUMC. Primary cultures were prepared as 
described [29].  Cells were seeded and grown in DME/F12 supplemented with 5% 
heat-inactivated fetal bovine serum (FBS), 100 IU/ml penicillin G and 0.1 mg/ml 
streptomycin, 5 µg/mL insulin, 5 µg/mL transferrin, and 5 ng/mL sodium selenite 
(ITS). Cells were cultured on both filter supports (Transwell Costar, Corning, NY) 
and on plastic culture dishes.  When the cells were grown to confluency on filter 
supports, cell polarity of the cultures was confirmed by the achievement of a 
transepithelial electrical resistance by the cell monolayer, measured with an EVOMTM 
voltohmmeter (World Precision Instruments, Sarasota, Fl) as described [30].  In 
culture, both ADPKD and NHK cells are able to establish a monolayer, form tight 
junctional complexes, develop a transepithelial electrical potential difference and 
carry out an active transepithelial transport of salt and fluid [27, 29, 31].  As 
previously shown, these cells are epithelial in nature and the majority of the cells 
stain positive for specific lectin markers for the collecting duct and distal nephron, 
such as Arachis hypogaea (PNA) and Dolichos biflorus agglutinin (DBA) [25].  
Altogether, this suggests that both cell types are enriched in cells derived from distal 
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nephrons and collecting tubules.  In agreement with this observation, aquaporin-2, a 
marker for collecting tubules, was detected by immunoblot analysis in both NHK and 
ADPKD cells (Figure 1).    
 
Biochemical Assays 
Protein assays were performed using the dye-binding assay from Bio-Rad 
(Hercules, CA). Na,K-ATPase activity was determined on homogenates of NHK and 
ADPKD cells grown to confluency on filter supports or plastic dishes.  Specific ATP 
hydrolysis was determined by measuring the initial rate of release of 32Pi from γ[32P]-
ATP for 30 min at 37˚C in a final volume of 0.25 mL of medium containing 120 mM 
NaCl, 30 mM KCl, 3 mM MgCl2, 0.2 mM EGTA, 1 mM sodium azide, 30 mM Tris-
HCl (pH 7.4), 3 mM ATP with 0.2 µCi γ[32P]ATP, in the absence and presence of 
different ouabain concentrations [32]. 
 
Reverse transcriptase-polymerase chain reaction (RT-PCR) Analysis 
Total RNA was isolated using TRIzol reagent (Invitrogen Corp., Carlsbad, 
CA). Complementary DNA was generated by reverse transcription using the 
SuperScriptTM First-Strand Synthesis System (Invitrogen Corp., Carlsbad CA) and 
oligo (dT) primers as described [32].  The resulting first-strand cDNA was amplified 
using Na,K-ATPase isoform specific primers, and under PCR conditions that assure 
no cross-reactivity among the Na,K-ATPase isoforms.  The sequences of the primers 
used, their annealing properties and the size of the amplified cDNAs are described in 
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Table 1.  The amplified DNA fragments were identified by electrophoresis in a 1% 
agarose gel stained with ethidium bromide. 
 
Immunoblot analysis of Na,K-ATPase isoforms 
Cell proteins (30 µg) from homogenates of NHK and ADPKD cells grown to 
confluency on filter supports or plastic were analyzed by 8% SDS-PAGE for the α 
and β isoforms, or 16% tricine gels for the γ subunit and blotted onto nitrocellulose 
membranes (Osmonics Inc, Minnetonka, MN) as described [32, 33].  Primary 
antibodies specific for each Na,K-ATPase isoform were incubated overnight at 4˚C.  
Horseradish-peroxidase conjugated secondary antibodies and chemiluminescence was 
used for detection. 
 
Measurement of cell proliferation 
NHK and ADPKD cells (4,000 cells/well) were seeded onto a 96-well plate 
with culture medium supplemented with 1% FBS and ITS. After 24 h, ITS was 
removed and the serum concentration was reduced to 0.002%.  After an additional 24 
h, the cells were treated with control medium or with various concentrations of 
ouabain for 24 h.  Cell proliferation was determined using the Promega CellTiter 96 
MTT Assay according to the manufacturer recommendations (Promega Corp., 
Madison, WI).  This method is based on the metabolism of a tetrazolium salt by the 
cells, and the optical density of the formazan product formed is proportional to the 
metabolic activity, and the number of cells in the culture [34].  Proliferation rates 
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were also determined by counting cells with a hemocytometer. In all proliferation 
assays, data are presented as a percent of proliferation of untreated cells.  
 
Measurement of cell mitosis 
Cells (1 × 105) were seeded onto glass coverslips in culture medium 
supplemented with 1% FBS and ITS for 24 h.  After an additional 24 h in 0.002% 
FBS, subconfluent cell monolayers were treated with control medium or medium 
containing 3 × 10-9 M ouabain for 1, 3, 5, 8 and 24 h.  The cells were then fixed in 
100% methanol for 45 min at -20°C and washed three times for 5 min each in 0.1% 
Triton X-100 in PBS.  Samples were blocked for 1 h with 3% BSA in PBS and were 
incubated for 1 h with an antibody against Ser-10-phospho-Histone H3, a marker for 
mitosis (Upstate Biotechnology, Lake Placid, NY).  Following three washes for 15 
min each in 0.1% Triton X-100 in PBS, cells were incubated for 1 h with an Alexa 
488 secondary goat anti-rabbit IgG (Molecular Probes, Eugene, OR).  Samples were 
stained with DAPI and mounted with SlowFadeR mounting solution (Molecular 
Probes, Eugene, OR).  Slides were analyzed using a Zeiss LSM510 confocal 
microscope.  Data were expressed as number of green fluorescent cells relative to the 
total cells per unit area.   At least 10 random fields were analyzed and a minimum of 
1,000 cells per time point were counted. 
 
Immunoblot analysis of phosphorylated ERK levels 
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NHK and ADPKD cells (1 × 105) were grown in 6-well plates under the same 
conditions as described above, and then treated with varying ouabain concentrations 
for 0, 15, 30, 60, 90, and 120 min.  In some experiments, ouabain was added to either 
the apical or basolateral side of ADPKD cell monolayers grown on filter supports, to 
determine if the ouabain-induced ERK activation was unique to one membrane 
domain.  In all cases, cells were washed with ice-cold PBS and lysed with 1% NP-40, 
0.25% sodium deoxycholate, 1 mM Na3VO4, 1 mM NaF, 150 mM NaCl, 1 mM 
EDTA, 50 mM Tris, and protease inhibitor cocktail (Sigma, St. Louis, MO, USA).  
The cleared lysates (15 µg total protein) were analyzed by 10% SDS-PAGE and 
blotted onto nitrocellulose membranes.  The immunoblots were first analyzed for 
levels of phosphorylated ERK, and then the membranes were stripped and probed for 
total ERK, using antibodies from Santa Cruz Biotechnology, Santa Cruz, CA.  After 
detection by chemiluminescence, the images were scanned and quantified for band 
intensity using the Gel-Pro software (Media Cybernetics, Inc., Silver Spring, MD).  
Levels of P-ERK and total ERK were expressed as density units relative to the 
untreated controls, and presented as P-ERK to total ERK ratios. 
 
Immunocytochemistry of Na,K-ATPase in ADPKD cells 
Cells were grown on filter supports until they were confluent, confirmed by 
the development of transepithelial electrical resistance.  Cells were fixed in 100% 
methanol for 45 min at -20°C and were subjected to immunocytochemistry as 
described [30].  An anti-α1 monoclonal antibody (6F, Developmental Studies 
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Hybridoma Bank, University of Iowa) was used, followed by an Alexa Fluor 594 
conjugated secondary antibody (Molecular Probes, Eugene, OR).  Slides were 
analyzed using a Zeiss LSM510 confocal microscope. Images were acquired in 
Multitrack channel mode with LSM510 (v 3.2) software and a Plan-Apochromat 
63X/1.4 Oil DIC objective with a frame size of 1024X1024 pixels and a zoom factor 
of 2. z line views were obtained by averaging 10 sections over a line at each z 
position in 1.0 μm steps. 
 
Data analysis   
Curve fitting of the experimental points was performed using a Marquardt 
least-squares non linear regression computing program (Sigma Plot, Jandel Scientific, 
San Rafael, CA).  Dose-response relations for the ouabain inhibition of Na,K-ATPase 
activity were fitted by equations assuming the presence of one, or two enzyme 
populations with different affinity for ouabain as previously described [32].  The 
validity of using a two versus a single component regression model for ouabain 
binding was statistically supported by applying the Snedecor’s F test [35].  Statistical 
significance of the differences between ouabain treated and untreated controls was 
determined by ANOVA, while differences between normal and cystic cells were 
analyzed by Student’s t-test. Statistical significance was defined as P< 0.05. 
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RESULTS 
Effect of ouabain on proliferation of NHK and ADPKD cells 
Ouabain binding to the Na,K-ATPase causes induction of various 
transcription factors and up-regulation of genes involved in cell growth [15].  To 
determine whether ouabain affects the proliferation of NHK and ADPKD cells, we 
measured the rate of cell proliferation in the presence of various concentrations of 
ouabain using a proliferation assay.  Surprisingly, concentrations of ouabain as low 
as 10-10 M and in the nanomolar range (1 × 10-10 M to 3 × 10-8 M) significantly 
increased the rate of proliferation of ADPKD cells (30% to 40%) compared to 
ADPKD cells in control medium (Figure 2A).  Concentrations below 10-10 M had 
no significant effect, while concentrations at 10-7 M and higher instead inhibited 
cell proliferation, corresponding with extensive inhibition of Na,K-ATPase activity 
[4, 19].  In contrast, nanomolar ouabain concentrations did not have a statistically 
significant effect on the proliferation of NHK cells.  The ouabain effect on cell 
proliferation was also determined by direct cell count using a hemocytometer 
(Figure 2B).  These data confirm that ouabain increased the proliferation of 
ADPKD cells in a dose dependent manner, but had no significant effect on the 
growth of NHK cells.  The same results were obtained when the NHK cells were 
grown at a lower cell density (data not shown), suggesting that the lack of effect of 
ouabain on cell proliferation was not due to the extent of cell confluency, but rather 
depended on the particular response of the cells to the steroid.   
To further examine the effect of ouabain on cell proliferation, we measured 
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the number of mitotic cells in cultures of NHK and ADPKD cells 1, 3, 5, 8 and 24 h 
following treatment with 3 × 10-9 M ouabain (Figure 3).  Phosphorylation of histone 
H3 is a commonly used marker for cell division [11], which correlates with the 
chromosomal condensation that accompanies the onset of mitosis.  Treatment with 
ouabain for 1 h increased the number of ADPKD cells that stained positive for 
phospho-histone H3 (% of total cell number) approximately two-fold compared to 
the untreated cells.  The mitotic index (% of phospho-histone H3 positive cells) for 
ADPKD cells treated with ouabain increased three-fold at 3 h, and remained 
elevated throughout the 24 h incubation period (Figure 3B).  In contrast, ouabain 
caused only a small increase in the mitosis of NHK cells at 3 h of incubation, with 
no significant difference between the ouabain treated and control groups at other 
timepoints (Fig. 3A).  Altogether, these results demonstrate that nanomolar 
concentrations of ouabain promote the proliferation of human ADPKD cells grown 
in culture. 
 
Effect of ouabain on ERK activity in human ADPKD cells 
In several cell types, ouabain has been shown to stimulate cell growth 
through activation of the MEK-ERK pathway [15].  To determine if these mediators 
are involved in the ouabain induced proliferation of ADPKD cells, we measured the 
levels of phosphorylated ERK (P-ERK) in the cells after treatment with different 
concentrations of ouabain for various times, from 0 to 120 min.  The effect of 3 × 
10-9 M ouabain on P-ERK to total ERK ratios for NHK and ADPKD cells is 
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presented in Figures 4A and 4B.  Consistent with the lack of an effect of ouabain on 
cell proliferation, ouabain did not significantly alter ERK activity in NHK cells 
(Figure 4A).  In contrast, ouabain increased P-ERK levels in ADPKD cells within 
15 min after treatment with the steroid (Figure 4B).  ERK phosphorylation 
remained elevated during the following 60 min incubation and, although levels 
were slightly lower, significant amounts of P-ERK were still observed by 120 min.  
There was no change in P-ERK levels in ADPKD cells incubated with control 
medium without ouabain for each time point (data not shown).  Similar time-course 
responses were observed at 10-9, 10-8 and 3 × 10-8 M ouabain (data not shown).  
Analysis of the relative levels of ERK activation by different concentrations of 
ouabain indicated a dose dependent relationship.  Below concentrations of 10-10 M, 
ouabain had no significant effect, while induction of ERK phosphorylation was 
detected with 10-10 M ouabain, and P-ERK increased at ouabain concentrations 
between 1 × 10-9 M and 3 × 10-8 M.  In contrast, higher ouabain amounts (10-7 M), 
known to significantly block Na,K-ATPase activity, failed to elevate P-ERK levels 
(Figure 4C).  Altogether, these results suggest that ouabain induced ADPKD cell 
proliferation is mediated via ERK activation, and this response occurs within 
minutes of the addition of nanomolar concentrations of the steroid. 
To determine whether ERK activation by ouabain occurs from the apical or 
basal side of the ADPKD cells, levels of P-ERK were determined in confluent 
cultures grown on filter supports.  Apical application of ouabain had no effect on P-
ERK levels.  In contrast, ouabain applied to the basal compartment of the culture 
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chamber caused activation of ERK (Figure 5A).  In addition, as was observed in the 
subconfluent cultures (Figures 2, 3 and 4), the NHK monolayer grown on filter 
support did not show ERK activation after treatment with ouabain, either when the 
steroid was applied from the apical or basolateral surface of the cells (Fig. 5B).  In 
agreement with the effect of ouabain occurring through the Na,K-ATPase in 
ADPKD cells, immunocytochemical analyses of the α1 isoform of the enzyme 
showed it to be restricted to the basolateral membrane domain of the ADPKD cells, 
a distribution that is similar to that of the normal kidney cells (Figure 5C).  These 
results suggest that ouabain acts from the serosal side of ADPKD cells, and are in 
agreement with the notion that ERK activation is mediated by the Na,K-ATPase 
restricted to the basolateral membrane of the cells. 
To confirm that the MEK-ERK pathway is central for ouabain-induced 
proliferation of ADPKD cells, we compared the effect of ouabain in the absence 
and presence of the MEK inhibitor U0126.  We found that 1 μM U0126 completely 
blocked the ouabain induced proliferation of ADPKD cells (Figure 6A).  
Accordingly, U0126 prevented the phosphorylation of ERK caused by ouabain 
(Figure 6B).  Also, U0126 decreased ADPKD cell proliferation to levels lower than 
untreated controls.  This suggests an important role of the MEK-ERK pathway in 
the growth of ADPKD cells.  More importantly, the ability of U0126 to counteract 
the effects of ouabain strongly suggests that ouabain-induced proliferation in 
ADPKD cells is mediated through activation of MEK-ERK and not through another 
pathway.  
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Ouabain sensitivity of Na,K-ATPase in NHK and ADPKD Cells.  
To determine whether the difference in the proliferative response of NHK 
and ADPKD cells to ouabain was due to differences in the affinity of the Na,K-
ATPase to the steroid, we examined the ouabain kinetic response of the Na,K-
ATPase of NHK and ADPKD cells.  For this, dose-response curves for the 
inhibition of Na,K-ATPase activity by ouabain were determined (Figure 7). NHK 
cells exhibited a monophasic ouabain inhibition profile (Figure 7A), with a ouabain 
inhibition constant (Ki) of 0.48 + 0.05 × 10-6 M, consistent with what has been 
described in normal kidney [3, 4, 36].  In contrast, ADPKD cells showed a 
heterogeneous response, with two Na,K-ATPase populations with different 
affinities for ouabain.  Approximately 80% of the total Na,K-ATPase had a Ki for 
ouabain (1.3 + 2.0 × 10-6 M) similar to that of normal kidney cells.  Surprisingly, the 
remaining 20% of the enzyme showed a sensitivity for ouabain that was three 
orders of magnitude higher, with a Ki of 1.7 + 4.7 × 10-9 M (Figure 7B).  The 
finding that an important fraction of Na,K-ATPase expressed in ADPKD cells has a 
high affinity for ouabain suggests that the enzyme would be more susceptible to 
binding the steroid at nanomolar concentrations such as those found in plasma.  
 
Na,K-ATPase isoform expression in NHK and ADPKD cells 
Generally, heterogeneous response to ouabain reflects the expression of 
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different isozymes of the Na,K-ATPase [3].  Normal kidney expresses 
predominantly one isozyme of the Na,K-ATPase, composed of α1 and β1 isoforms 
[3, 4].  In the current study, the Ki for the more resistant Na,K-ATPase component 
observed in both the NHK and ADPKD cells is consistent with the ouabain kinetics 
corresponding to the α1β1 isozyme [36].  The high ouabain sensitive Na,K-ATPase 
unique to the cystic cells, suggested the presence of additional α or β isoforms.  To 
explore the expression pattern of the Na,K-ATPase α and β isoforms in the kidney 
cells at the RNA level, we used RT-PCR employing the primer sets described in 
Table 1.  Figures 8A and 8C show that cDNAs for only the α1 and β1 isoforms 
were amplified from the normal and ADPKD cells.  This agrees with previous 
results showing that only the α1β1 isozyme is present in kidneys [3].  The 
specificity of the Na,K-ATPase primers used was confirmed by the lack of cross 
reactivity with cDNAs of α isoforms other than that containing the corresponding 
complementary sequence.  In addition, PCR reactions performed in the absence of 
reverse transcription yielded no Na,K-ATPase isoform products, indicating the lack 
of genomic DNA contamination in the RNA isolation step (data not shown).  
To determine the expression of the Na,K-ATPase isoforms at the protein 
level, immunoblot analysis of kidney cell total proteins was performed using 
antibodies specific for the α and β isoforms.  In agreement with the RT-PCR 
analysis, the protein profile of Na,K-ATPase subunits demonstrated that only the α1 
and β1 isoforms were present in NHK and ADPKD cells (Figures 8B and 8D). The 
α2, α3, α4, β2 and β3 isoforms were absent, and only observed in human brain and 
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testis (used as positive controls), which express different combinations of the Na,K-
ATPase isoforms (first lane in Figures 8A-D).  
In addition, RT-PCR and immunoblot analysis was performed for the Na,K-
ATPase γ subunit (Figures 8E and 8F).  This showed that both γa and γb variants of 
the enzyme are expressed in the cells.  Interestingly, relative to the ubiquitously 
expressed glyceraldehyde phosphate dehydrogenase (GAPDH), the levels of γ 
expression were higher in ADPKD than NHK cells, both at the RNA and protein 
levels. Based on the RT-PCR and immunoblot analysis, we conclude that NHK and 
ADPKD cells present similar Na,K-ATPase isozyme expression profiles and that 
the γ variants of the enzyme are up-regulated in ADPKD cells. 
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DISCUSSION 
 The present results demonstrate that epithelial cells derived from renal cysts 
of patients with ADPKD have an abnormal mitogenic response to nanomolar 
concentrations of ouabain. This was reflected by an increase in cell proliferation as 
detected by the MTT assay, by an enhanced mitotic index, and by an increase in cell 
number. These findings provide new evidence that ouabain binding to the Na,K-
ATPase not only modulates the ion transport of the enzyme, but also induces growth 
signals in cells [15].  The proliferative action of ouabain is apparent in ADPKD cells, 
and NHK cells are not significantly affected by the steroid.  The NHK and ADPKD 
cells used in this study appear to be largely derived from distal convoluted and 
collecting tubules, based on lectin markers and by the existence of transport 
mechanisms expressed in those nephron segments ([25, 29, 31] and Figure 1).  The 
similar origin of the cells suggests that the changes in ouabain response observed are 
a consequence of the cellular phenotype of normal renal epithelial cells versus mural 
cystic cells, and not due to differences in the progenitor cell type.  The proliferative 
effects of ouabain have been described in various cell types, including normal 
proximal tubule cells of the rat kidney [11, 37].  Although we could not detect 
statistically significant differences in the NHK cells, we observed a trend for an 
increase in ouabain-dependent proliferation in these cells.  The different magnitude in 
ouabain response reported for normal rat cells, compared to human cells may just 
reflect differences between species. 
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 Sensitivity of the Na,K-ATPase to ouabain is of critical importance in the 
response to the cardiotonic steroid [3, 4].  In contrast to NHK cells, ADPKD cells 
express a population of Na,K-ATPase that has an abnormally high affinity for 
ouabain.  The cause of the unique ouabain sensitivity phenotype of ADPKD cells was 
not due to the aberrant expression of Na,K-ATPase isoforms, since only the α1β1 
isozyme was present in the cells.  The α1 isoform expression we observe agrees well 
with previous reports for normal and cystic human kidney [38].  Our results also 
confirm the expression of β1 in ADPKD.  Although the potential for expression of 
the β2 subunit has been reported in human ADPKD kidneys [38], we were unable to 
detect it in the cultured cyst epithelial cells.  It is well established that the binding 
sites for ouabain are located on the α subunit, and the β polypeptide does not 
influence the ouabain binding kinetics of the Na,K-ATPase [3, 35].  Therefore, it is 
clear that the change in proliferative response to ouabain in the ADPKD cells was not 
due to expression of α2, α3, α4 or the β isoforms.  Interestingly, we found that while 
γa and γb are both present in NHK and ADPKD cells, the γ polypeptides are up-
regulated in ADPKD cells.  The γ subunit has been shown to be a regulator of Na,K-
ATPase function and it influences the kinetic properties of the enzyme [33].  It is 
possible then, that the increased γ polypeptide content of ADPKD cells may favor its 
interaction with the enzyme and thus, the response to ouabain.  Additional 
explanations for the particular ouabain affinity of ADPKD cells include the 
expression of a yet to be identified isoform of the Na,K-ATPase, or mutations in the 
α1 polypeptide that render the enzyme more sensitive to ouabain.  Alternatively, 
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ouabain affinity may depend on interaction between the Na,K-ATPase and other 
proteins.  The large intracellular region of the Na,K-ATPase between transmembrane 
domains 4 and 5 has been shown to interact with the C-terminus of polycystin 1 [39, 
40].  Interestingly, we found that, in insect cells exogenous expression of a construct 
containing the transmembrane and C-terminal domains of polycystin 1 increases the 
sensitivity of the Na,K-ATPase to ouabain, with the enzyme exhibiting an inhibition 
constant for the steroid that is similar to that found in ADPKD cells [41].  Therefore, 
Na,K-ATPase-protein interaction represents another potential mechanism involved in 
the response of the cells to ouabain. Despite the mechanisms involved, ADPKD cells 
express a pool of the Na,K-ATPase that is more susceptible to bind and transmit  the 
mitogenic signal of ouabain.  
 Activation of the mitogen-activated protein kinase (MAPK) pathway plays a 
primary role in proliferation of ADPKD cells.  For example, the epidermal and 
transforming growth factors (EGF and TGFα respectively) elicit mitogenic effect in 
ADPKD cells by the MEK-ERK pathway through binding to receptor tyrosine kinase 
[21-24], and cAMP promotes growth and secretion of ADPKD cells via B-
Raf/MEK/ERK [21, 42].  Our results show that ouabain caused phosphorylation of 
ERK in ADPKD cells within 15 min of addition of the steroid, ERK phosphorylation 
was maximal at nanomolar ouabain concentrations, and inhibition of MEK blocked 
the effect.  These results confirm the role of the MEK-ERK pathway in the mitogenic 
effect of ouabain, and identify MEK and ERK as mediators of ouabain proliferation 
in ADPKD cells [15].  The kinetics of ERK phosphorylation and cell proliferation 
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induced by ouabain are in good agreement. The relatively higher response in cell 
proliferation compared to P-ERK levels at 10-10 M ouabain may reflect differences in 
the sensitivity of the experimental methods used, or it may indicate that submaximal 
ERK activation may be sufficient to cause a prominent effect on ADPKD cell 
proliferation.   
 Importantly, the ERK phosphorylation mediated by ouabain was observed not 
only in ADPKD cells that had not reached confluency (see Figures 2, 3, 4 and 6), but 
also in confluent cell cultures (see Figure 5), suggesting that the steroid is also 
capable of inducing growth of the cyst epithelium.  A relatively lower ouabain 
dependent ERK phosphorylation level was found in confluent compared to sub-
confluent cultures.  We reason that the culture filter support limits ouabain 
accessibility to the basolateral side of the cells, where the Na,K-ATPase is localized. 
Alternatively, different from the subconfluent cultures, the tight monolayer 
established by ADPKD cells, and the extensive formation of junctional complexes in 
the cultures may restrict the access of ouabain to the basolateral surface of the cells.  
In any case, both under subconfluent or confluent conditions, ADPKD cells exhibit a 
ouabain response that is not observed in NHK cells.  
 Importantly, ERK activation by ouabain in ADPKD cells is only elicited if the 
cardiotonic steroid is applied to the basal side of the culture.  Our observation that 
Na,K-ATPase expression is limited to the basolateral membrane domain of the cells 
agrees with previous observations [24, 28, 29], and with the notion that ouabain 
signal is transmitted through the Na,K-ATPase.  
  41
 The effect of ouabain through its receptor, the Na,K-ATPase resembles the 
non-genomic actions of other steroids.  Strong evidence now supports the idea that 
steroids can bind to cell surface proteins to trigger downstream signaling cascades in 
the cell [43].  Rapid effects of estrogen and aldosterone via plasma membrane 
transport mechanisms, such as Ca2+- and voltage-activated K+ channels and the 
Na+/H+ exchanger have been reported [44, 45].  The effect of ouabain in ADPKD 
cells is consistent with that observed in several other cell types, where ouabain 
binding to the Na,K-ATPase triggers ERK phosphorylation [15].  The presence of the 
lactone ring and sugar moieties in the steroidal structure of ouabain are important for 
specific binding to the Na,K-ATPase, the only known receptor to date for the 
compound [15, 46].  This, together with the presence of Na,K-ATPase high affinity 
ouabain sites, and the restricted basolateral effect of ouabain that coincides with the 
localization of the enzyme in ADPKD cells, strongly supports that ouabain dependent 
intracellular signaling in the cells occurs through the Na,K-ATPase. 
 The effect of ouabain on proliferation of ADPKD cells takes place at 
nanomolar concentrations.  These ouabain amounts correspond to the levels of 
ouabain reported in blood [8]. Therefore, under physiological conditions, endogenous 
ouabain can readily activate the MEK-ERK pathway in the cyst cells of ADPKD 
kidneys, representing a factor that may directly promote the growth of the cysts.  A 
variety of circulating factors, hormones and autacoids have been shown to stimulate 
the proliferation of renal cyst epithelial cells [21-23, 26, 27, 47, 48]. This study is the 
first to demonstrate that ouabain, an endogenous steroid hormone has a positive effect 
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on proliferation of ADPKD cells.  Compounds that antagonize the action of ouabain 
are under development [49] and will represent an important tool for further 
understanding ouabain effect in ADPKD and for an eventual clinical intervention of 
the disease. 
 In conclusion, we found that ADPKD cells express a population of Na,K-
ATPase that has a high affinity for ouabain, and respond to the steroid with an 
increase in proliferation mediated by the MEK-ERK pathway. The potential for 
endogenous ouabain as well as exogenous cardiotonic steroids to influence cyst mural 
cell growth is of clinical relevance for the progression of the disease. 
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Figure 1.  Expression of Aquaporin-2 in NHK and ADPKD cells. Proteins from 
normal and cystic cell homogenates were separated by SDS/PAGE, transferred to 
nitrocellulose and immunoblotted using an anti-Aquaporin-2 antibody (Sigma 
Chemical Co., St. Louis, MO). A horseradish peroxidase conjugated secondary 
antibody and chemiluminescence was used for detection. 
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Figure 2 
 
 
Ouabain [M]
%
 C
el
l P
ro
lif
er
at
io
n
0
10
-12
10
-11
10
-10
3x
10
-10 10
-9
3x
10
-9
10
-8
3x
10
-8
10
-7
3x
10
-7
10
-6
0
20
40
60
80
100
120
140
160
NHK Prolif. 
ADPKD Prolif. 
*
*
**
*
*
*
*
*
**
** ** **
**
***
**
*
A
0
20
40
60
80
100
120
140
160
N
um
be
r o
f c
el
ls
 (%
)
0
10
-12
10
-11
10
-10
10
-9
10
-8
10
-7
Ouabain [M]
B
NHK  
ADPKD #
*
##
** #
*
* *
%
 C
el
l P
ro
lif
er
at
io
n
N
um
be
r o
f c
el
ls
 (%
)
N
um
be
r o
f c
el
ls
 (%
)
 
  - 52 - 
Figure 2.  Effect of ouabain on NHK and ADPKD cell proliferation. (A) Cells were 
grown in 96 well plates, serum starved for 24 h and treated with control medium or 
media containing the indicated ouabain concentrations for an additional 24 h. Cell 
number was determined using the CellTiter 96 MTT assay. For ADPKD cells, data 
represent 18 experiments performed in sextuplicate on cells obtained from 8 different 
ADPKD kidneys. For NHK cells, data represent 15 experiments performed in 
sextuplicate on 7 different normal kidneys. Bars represent the mean + SE normalized 
to the respective untreated controls. Absolute optical density (OD) values at zero 
ouabain were 0.23 + 0.04 and 0.15 + 0.01 for NHK and ADPKD respectively.  (*) 
P<0.001 compared to untreated controls; (**) P<0.001 compared to the 
corresponding values in NHK cells. (B) Cells were grown in 24 well plates, and 
treated without and with the indicated ouabain concentrations as mentioned in A. Cell 
number was determined with a hemocytometer. Data represent the mean + SE of 16-
32 determinations performed in cells obtained from two kidneys. Average cell 
number at zero ouabain was 68 + 5 x 104 and 40 + 4 x 104 for NHK and ADPKD cells 
respectively. (*) P<0.05, and (**), P<0.001 compared to untreated controls; and (#) 
P<0.05 and (##) P<0.001 compared to the corresponding values in NHK cells. For 
NHK cells, similar results were obtained at lower cell densities, such as those of the 
ADPKD cells. This was observed both with the CellTiter 96 MTT proliferation and 
cell count assays, in which the average OD and cell number values at zero ouabain 
were 0.15 + 0.02 and 39 + 2 x 104 cells respectively (data not shown). 
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Figure 3 
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Figure 3.  Ouabain effect on cell mitosis in (A) normal and (B) cystic kidney cells. 
NHK and ADPKD cultures grown at the same cell density were treated for the 
indicated times with 3 × 10-9 M ouabain and mitosis was determined by detection of 
phospho-Histone H3 using immunocytochemistry. The number of mitotic cells are 
presented as percent of phospho-histone H3 positive cell nuclei relative to total cell 
nuclei, identified by DAPI staining. Bars represent the mean + SE of 3 separate 
experiments (with at least 1,000 cells/time point analyzed per experiment) from 3 
different kidneys. Asterisks indicates significant differences from the corresponding 
untreated controls, with *, P<0.05; and ** P<0.001. 
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Figure 4 
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Figure 4.  Ouabain activation of ERK in NHK and ADPKD cells. (A,B) time-course 
effect in NHK and ADPKD cells respectively. Same number of NHK and ADPKD 
cells were treated with 3 × 10-9 M ouabain for the indicated times. Vehicle controls 
without ouabain performed at each time point showed similar ERK phosphorylation 
levels as zero time. (C) Dose-response effect of ouabain in ERK phosphorylation in 
ADPKD cells. Cells were treated with the indicated ouabain concentrations for 15 
min. Cells were lysed and cell proteins were subjected to immunoblot for 
determination of the total and phosphorylated forms of ERK. Representative 
immunoblots are shown. Bar graphs represent the densitometric analysis of the blots. 
Values are relative P-ERK/total ERK, presented as a ratio of the untreated controls.  
Bars indicate the mean + SE of six determinations from three different kidneys for 
NHK (A), ten determinations from three kidneys for ADPKD (B), or 3 to 12 
determinations depending on ouabain concentration from two kidneys. *, P<0.05; **, 
P<0.001. compared to zero time in B, or to untreated control in C. 
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Figure 5 
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Figure 5.  Effect of apical and basolateral ouabain on ERK activation in polarized 
ADPKD and NHK monolayers. Activation of ERK was determined in confluent 
polarized ADPKD (A) and NHK (B) cells after treatment with 3 × 10-9 M ouabain for 
30 min. Ouabain was applied either to the apical or basolateral side of the culture. In 
the controls, the media from the apical or basolateral side of the culture chambers was 
also replaced with media lacking ouabain. Cells were then lysed and cellular proteins 
were subjected to immunoblot for determination of the total and phosphorylated 
forms of ERK. A representative immunoblot is shown. Values are P-ERK/total ERK, 
relative to the untreated controls.  Bars indicate the mean + SE of six determinations 
performed on three different kidneys for ADPKD cells, and four determinations 
performed on two different kidneys for NHK cells. Asterisks indicates P<0.001 
compared to the respective control without ouabain. (C) Immunocytochemical 
analysis of Na,K-ATPase expression in NHK and ADPKD cells. Cells were fixed and 
the Na,K-ATPase α1 isoform was detected by immunofluorescence using a 
monoclonal 6F antibody. Alexa Fluor 594 conjugated goat anti-mouse antiserum was 
used as the secondary antibody. DAPI was included to stain the nuclei. Top panels 
show z-line views positioned at the lines indicated in the x-y views shown in the 
bottom panels. ap, apical; bl, basolateral side of the cells. 
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Figure 6.  Effect of MEK inhibition on ouabain-induced cell proliferation and ERK 
activation in ADPKD cells. ADPKD cells were treated with 3 × 10-9 M ouabain in the 
absence and presence of 1 μM of the MEK inhibitor U0126. Then, the proliferation of 
ADPKD cells (A) and ERK phosphorylation levels in the cells (B) were evaluated. In 
A, bars indicate the mean + SE of three experiments performed in sextuplicates in 
cells obtained from 3 kidneys. In B, bars represent the mean + SE of six 
determinations performed on cells obtained from 2 kidneys. A representative 
immunoblot is shown. Asterisks indicate significant differences compared to 
untreated controls, with  P<0.001. 
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Figure 7.  Dose-response curves for the ouabain inhibition of Na,K-ATPase from 
human renal normal, NHK (A) and cystic, ADPKD (B) epithelial cells. Na,K-ATPase 
was determined in medium containing 120 mM NaCl, 30 mM KCl, 3 mM MgCl2, 0.2 
mM EGTA, 1 mM sodium azide, 30 mM Tris-HCl (pH 7.4), and 3 mM ATP, in the 
absence and presence of the indicated concentrations of ouabain. Na,K-ATPase 
activity was determined from the difference between the Na+ and K+-dependent 
hydrolysis of ATP in the absence or presence of the different ouabain concentrations. 
Data are expressed as percentage of the Na,K-ATPase activity in the absence of the 
inhibitor. Dose-response curves represent the best fit of the data assuming the 
presence of one (NHK) or two (ADPKD) Na,K-ATPase populations with different 
affinities for ouabain. The validity of the use of a two component fit model for the 
ADPKD cells was corroborated using a F test, with P<0.01. The inhibition constants 
(Ki) for each ouabain sensitive enzyme population are shown. Each data point is the 
mean + SE of the mean of quintuplicate determinations from 3 experiments performed 
in cells from two different kidneys. 
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Figure 8.  Na,K-ATPase isoform expression in normal and cystic human kidney cells. 
(A,C,E) Total RNA isolated from NHK and ADPKD cells was subjected to reverse 
transcription and the cDNA was amplified by PCR using oligonucleotides specific for 
each α and β isoforms, and for the γ subunit of the Na,K-ATPase (see Table 1). Full-
length cDNA for each subunit served as a control for specificity of the primers used. 
(B,D,F) Immunoblot analysis of α and β isoforms and γ variants in NHK and 
ADPKD cells. Proteins from the different cell types were separated by SDS/PAGE, 
transferred to nitrocellulose and subjected to immunoblot analysis. For the α1 
isoform, the monoclonal 6F antibody was used. For α2, the MCB2 antibody, kindly 
provided by K Sweadner (Massachusetts General Hospital) was used. The α3 and β1 
isoforms were detected with monoclonal antibodies MA3-915 and M17-P5-F11 
respectively (Affinity Bioreagents, Golden, CO). An anti-α4 antiserum raised against 
the N-terminus of the protein was used to identify α4. For β2, an antiserum 
generously provided by P. Martin-Vasallo was used (Universidad de La Laguna, 
Tenerife, Spain). For β3, a monoclonal antibody from BD Biosciences (San Jose, CA) 
was used. For the γ subunits, a polyclonal antibody γ969 provided by R. Mercer 
(Washington University in St. Louis) was used. Expression of GAPDH was 
determined, using a monoclonal antibody from Abcam Inc, Cambridge, MA. As a 
positive control for α1, α2, α3, β1, β2 and β3, human brain was used, for α4, human 
testis was used and the γ control was produced in Sf-9 cells using baculoviruses. 
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Table 1.  Characteristics of the primers that were used for RT-PCR analysis of Na,K-
ATPase isoforms in normal and cystic human kidney epithelial cellsa 
 
Gene Targeted 
(Accession 
No.) 
Primer Sequence Primer 
Position 
Product 
Size 
(bp) 
Annealing 
Conditions 
α1 
(NM_000701) 
5'-CTT AGC CTT GAT GAA CTT CA-3' (S) 
5'-ACT TCC TCC GCA TTT ATG CTC ATT-3' 
(AS) 
136 to 
535 
399 55˚C, 30s 
α2 
(NM_000702) 
5'-ATG ACC ACA AGC TGT CCT TG-3' (S) 
5'-GTT GAT CTG CAT CTT CTC TC-3' (AS) 
120 to 
538 
418 65˚C, 5s 
α3 
(NM_152296) 
5'-AAT CGA CGA GAT CCT GCA GAA T-3' (S) 
5'-GCT TTC GGC AGC CTC GTA C-3' (AS) 
2001 to 
2456 
455 50˚C, 30s 
α4 
(NM_086379) 
5'-CCA TAG CCA CCA AAG GGC AA-3' (S) 
5'-CAG CCA ACC ATA GCC CAA GA-3' (AS) 
211 to 
959 
748 55˚C, 30s 
 
β1 
(NM_001677) 
5'-TTG AAT GGC TGG GAA ATT GCT CTG 
GA-3' (S) 
5'-TTC TCA CCG TAC GCC TTA CAC TCT 
ATG-3' (AS) 
578 to 
965 
387 55˚C, 30s 
 
β2 
(NM_001678) 
5'-CAG GTG GTT GAG GAG TGG AAG G-3' (S) 
5'-CTT GCA TAG AGT CGT TGT AAG GCT C-3' 
(AS) 
34 to 
350 
316 50˚C, 30s 
 
β3 
(NM_001679) 
5'-GAC CAG ATT CCT AGC CCA GGA C-3' (S) 
5'-TTA AGT CTA TCA TTC CAT TAT GAG 
GAT AAA CTG CT-3' (AS) 
220 to 
637 
417 50˚C, 30s 
γa 
(NM_001680) 
5'-ACT GGG TTG TCG ATG GAC GGT-3' (S) 
5'-CGG CTC ATC TTC ATT GAT TTG-3' (AS) 
4 to 192 188 44˚C, 30s 
γb 
(NM_021603) 
5'-GAC AGG TGG TAC CTG-3' (S) 
5'-CGG CTC ATC TTC ATT GAT TTG-3' (AS) 
4 to 192 188 44˚C, 30s 
aAS, antisense primer; RT-PCR, reverse transcriptase-PCR; S, sense primer 
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CHAPTER 3 
Na,K-ATPase-OUABAIN SIGNALING PATHWAY IN ADPKD CELLS 
ABSTRACT 
 The Na,K-ATPase acts as a signal transducer that mediates the effects of the 
hormone ouabain in several cell types.  We have shown that concentrations of 
ouabain, such as those circulating in blood, stimulated growth of epithelial cells 
derived from renal cysts of patients with autosomal dominant polycystic kidney 
disease (ADPKD cells).  In this study, we investigated the signaling pathway 
triggered by ouabain in the cells.  Ouabain stimulated phosphorylation of the 
epidermal growth factor receptor (EGFR) and the tyrosine kinase Src in ADPKD 
cells.  Ouabain also enhanced interaction between the Na,K-ATPase and EGFR.  
Tyrphostin AG1478 and PP2, inhibitors of EGFR and Src respectively, blocked the 
proliferative effects of ouabain in the cells.  Ouabain-Na,K-ATPase signaling in 
ADPKD cells required the integrity of plasma membrane caveolae, and disruption of 
caveolae by cholesterol depletion with methyl-β-cyclodextrin prevented ouabain-
induced effects in the cells.  Moreover, ouabain promoted phosphorylation of 
caveolin-1, a major protein of cell caveolae.  Downstream effects of ouabain included 
phosphorylation of the kinase B-Raf, and the extracellular regulated kinase ERK.  
Activation of ERK by ouabain resulted in translocation of this kinase into the cell 
nuclei.  Finally, ouabain produced internalization of the Na,K-ATPase to the cell 
cytoplasm.  Altogether, these results suggest that ouabain-stimulated proliferation of 
ADPKD cells is mediated by transduction pathways that require the Na,K-ATPase 
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signaling complex within cell caveolae, the EGFR, Src, and the downstream B-Raf 
and MEK-ERK pathway.  
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INTRODUCTION 
 The enzyme Na,K-ATPase functions not only as a transporter that generates 
the Na+ and K+ gradients that typically exist across the cell plasma membrane, but is 
also a signaling molecule capable of mediating the effects of ouabain in the cell [1, 
2].  The Na,K-ATPase is an oligomer composed of two major polypeptides, a 
catalytic α and a glycosylated β subunit [3]. The α polypeptide represents the primary 
receptor and transducer of the effects of cardenolides, such as ouabain in the cell [4, 
5].  Ouabain is a well characterized steroidal hormone that is synthesized in the 
adrenal glands and is released into the circulation upon several stimuli [6]. Once in 
the bloodstream, ouabain reaches the target cells, and through the Na,K-ATPase, 
activates signaling events in the cells that induce changes in metabolism, motility and 
growth [7-12].  
 The signaling apparatus of the Na,K-ATPase, as well as the intracellular 
transduction pathways involved in ouabain-stimulated effects, have been 
characterized in several cell types  [7-12]. For example, in myocardial and epithelial 
cells, a subpopulation of Na,K-ATPase molecules has been identified as part of a 
signaling protein complex that resides within plasma membrane caveolae [13].  Upon 
ouabain binding, the Na,K-ATPase initiates a series of reactions that include 
interaction of the enzyme at the plasma membrane with neighboring proteins, and 
activation of the kinase Src.  This subsequently causes the recruitment and 
phosphorylation of the epidermal growth factor receptor (EGFR), and of downstream 
members of the mitogen activated protein kinase (MAPK) pathway, such as the 
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extracellular regulated kinase ERK. This finally results in expression of a series of 
genes in the cells [1, 2, 9, 10, 13-16]. 
 Studies in our laboratory have shown that signaling through the Na,K-ATPase 
is functional and has important effects in epithelial cells from kidney cysts of patients 
with autosomal dominant polycystic kidney disease (ADPKD cells) [15].  ADPKD is 
the most common inherited disease of the kidney, characterized by the formation and 
progressive expansion of multiple fluid-filled cysts that distort the structure and 
severely compromises the function of the organ.  Interestingly, we have found that 
ADPKD cells exhibit an abnormally high affinity for ouabain, and in concentrations 
similar to those circulating in blood, ouabain stimulates ADPKD cell growth.  In 
contrast, ouabain does not significantly affect proliferation of normal human kidney 
epithelial cells (NHK cells) [15]. 
 The aberrant proliferation of the renal epithelial cells is one of the hallmarks 
of ADPKD, and represents an essential event in the development of renal 
cystogenesis [17-19]. Uncontrolled cell growth of the renal epithelium initially causes 
a focal expansion of the tubular renal epithelium, which eventually separate from the 
originating nephron and progress into fluid-filled vesicles [20-22]. Cysts then 
continue increasing their size through the combined effect of proliferation of the cells 
surrounding the cyst, and the constant secretion of fluid by the epithelium [21-23]. 
Although initiation of cyst formation is controlled by genetic events, identified as 
alterations in the Pkd1 and Pkd2  genes that encode for polycystin-1 and -2 (PC-1 and 
PC-2) respectively, the progressive enlargement of cysts appears to be regulated by a 
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variety of non-genetic factors [17-19, 24].  Various pharmacological and 
physiological agents have been shown to stimulate ADPKD cystogenesis.  For 
example, arginine vasopressin (AVP) and epidermal growth factor (EGF) stimulate 
cell proliferation of human ADPKD cells through activation of the MEK-ERK 
pathway; and cyclic AMP causes cell proliferation in human cells and animal models 
of polycystic kidney disease, also via the MEK-ERK pathway, through B-Raf, a 
kinase that phosphorylates and activates MEK [25-27].  Because of its mitogenic 
action and its stimulation of cell proliferation, ouabain emerges as a factor capable to 
affect renal cystic epithelial growth.  At present, the pathways involved in ouabain-
induced and Na,K-ATPase-mediated effects in ADPKD cells are unknown.  In the 
present study, we have investigated the signaling events triggered by physiological 
concentrations of ouabain in ADPKD cells.  We show that ouabain effects on 
proliferation of the cystic cells require interaction of the Na,K-ATPase with the 
caveolar protein caveolin, Src kinase, and the epidermal growth factor receptor 
(EGFR).  In addition, ouabain-Na,K-ATPase interaction results in activation of 
members of the MAPK pathway, and translocation of ERK to the cell nucleus.  
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METHODS 
Cell culture 
 Primary cell cultures derived from nephrectomy specimens of normal human 
kidney cortex (NHK cells) or surface cysts of ADPKD kidneys (ADPKD cells) were 
generated by the PKD Biomaterial Core at University of Kansas Medical Center 
(KUMC). The use of discarded human kidney tissues was approved by the 
Institutional Review Board at KUMC. Primary cultures were prepared as described 
[23]. Cells were seeded and grown in DME/F12 supplemented with 1% heat-
inactivated fetal bovine serum (FBS), 100 IU/ml penicillin G and 0.1 mg/ml 
streptomycin, 5 µg/mL insulin, 5 µg/mL transferrin, and 5 ng/mL sodium selenite 
(ITS).  24 hours before cells were subject to experimental manipulation, the serum 
was reduced to 0.002% and ITS was removed. Cells were cultured on both filter 
supports (Transwell Costar, Corning, NY) and on plastic culture dishes. When the 
cells were grown to confluency on filter supports, cell polarity of the cultures was 
confirmed by the achievement of a transepithelial electrical resistance by the cell 
monolayer, measured with an EVOMTM voltohmmeter (World Precision Instruments, 
Sarasota, Fl) as described [28]. ADPKD cells are able to establish a monolayer, form 
tight junctional complexes, develop a transepithelial electrical potential difference 
and they carry out an active transepithelial transport of salt and fluid [22, 23, 29]. As 
previously shown, these cells are epithelial in nature and the majority of the cells 
stain positive for specific lectin markers for the collecting duct and distal nephron, 
such as Arachis hypogaea (PNA) and Dolichos biflorus agglutinin (DBA), in addition 
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to specific transport proteins of those nephron segments [26].  This suggests that the 
cell are primarily derived from distal nephrons and collecting tubules. 
 
Measurement of cell proliferation 
 Cell proliferation was determined using the Promega CellTiter 96 MTT Assay 
according to the manufacturer recommendations (Promega Corp., Madison, WI). This 
method is based on the metabolism of a tetrazolium salt by the cells, and the optical 
density of the formazan product formed is proportional to the metabolic activity, and 
the number of cells in the culture [30]. In all proliferation assays, data are presented 
as a percent of proliferation of untreated cells.  
 
Immunoblot analysis  
 Cells were treated with and without 3 x 10-9 M ouabain for 30 min and in the 
absence and presence of the indicated inhibitors.  Cells were washed with ice-cold 
PBS and lysed with RIPA buffer containing, 1% NP-40, 0.25% Sodium 
deoxycholate, 1 mM Sodium orthovanadate, 1 mM NaF, 150 mM NaCl, 1 mM 
EDTA, 50 mM Tris, and 1x Protease inhibitor cocktail (Sigma, St. Louis, MO, USA).  
Total protein content in the cleared lysates was determined using the dye-binding 
assay from Bio-Rad (Hercules, CA). Equal amounts of total protein (15-30 µg) were 
analyzed by 10% SDS-PAGE and blotted onto nitrocellulose membranes (NitroBind, 
GE Water and Process Technologies, Trevose, PA). Immunoblots were first analyzed 
for levels of the phosphorylated forms of the proteins of interest, and then the 
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membranes were stripped and probed for the non-phosphorylated, or total forms of 
the polypeptides. The antibodies used to detect to the total and phosphorylated forms 
of the proteins of interest included the anti-Src from Biosource-Invitrogen, Faraday, 
CA; anti-EGFR from Upstate Cell Signaling, Lake Placid, NY; anti-caveolin from 
BD Biosciences, San Jose, CA; anti-B-Raf and anti-ERK from Santa Cruz 
Biotechnology, CA. Horseradish-peroxidase conjugated secondary antibodies and 
chemiluminescence was used for detection. The images were scanned and quantified 
for band intensity using the Gel-Pro software (Media Cybernetics, Inc., Silver Spring, 
MD). Levels of phosho- and total protein were expressed as density units relative to 
the untreated controls, and presented as phospho-to-total ratios. 
 
Immunoprecipitation assays 
 Immunoprecipitations were used to determine the ouabain-dependent association 
of the Na,K-ATPase with EGFR. ADPKD cells were treated with 3 x 10-9 M ouabain 
for 30 min. Cells were then lysed in RIPA buffer and subjected to 
immunoprecipitation. The anti-EGFR antibody and magnetic beads coated with 
secondary anti-rabbit antibody were used to pull down the polypeptide. After 
overnight incubation on a rocking surface at 4°C, the beads were isolated with a 
magnet and washed three times in RIPA buffer. The precipitated proteins were eluted 
in sample buffer (100 mM Tris HCl pH 6.8, 2% SDS, 33% glycerol, 100 mM DTT) 
for 15 min at 65°C, and were separated by SDS-PAGE (7.5% gel). Proteins were 
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transferred to nitrocellulose and were immunobloted for detection of the Na,K-
ATPase α subunit. 
 
Cholesterol Depletion and Repletion 
 Cholesterol depletion was obtained by treating the cells with methyl-β-
cyclodextrin (MβCD), 10 mM for 30 min at 37 °C as previously described [16].  Cells 
were washed twice in culture medium and incubated with or without 3 nM ouabain in 
the presence of 0.5 mM MβCD. Cells were then analyzed for proliferation, or for 
determination of activated ERK. In the cholesterol repletion experiments, cells that 
had been depleted from cholesterol, were treated in the culture medium with 40 µl/ml 
of cholesterol/ MβCD stock solution.  The cholesterol/ MβCD solution was prepared 
by mixing 200 µl of a 20 mg/ml solution of cholesterol in ethanol with 10 ml of 10% 
MβCD. 
 
Immunocytochemistry in ADPKD cells 
Cells were grown on glass coverslips or filter supports to confluency, confirmed 
by the development of transepithelial electrical resistance.  Cells were fixed in 100% 
methanol for 45 min at -20°C and were subjected to immunocytochemistry as 
described [28].  To detect the Na,K-ATPase, an anti-α1 monoclonal antibody was 
used (6F, Developmental Studies Hybridoma Bank, University of Iowa), while P-
ERK and P-B-Raf were detected using antibodies mentioned above, followed by an 
Alexa Fluor 488 (green) or 594 (red) conjugated secondary antibody (Molecular 
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Probes, Eugene, OR). Slides were analyzed using a Zeiss LSM510 confocal 
microscope. Images were acquired in Multitrack channel mode with LSM510 (v 3.2) 
software and a Plan-Apochromat 63x/1.4 Oil DIC objective with a frame size of 
1024x1024 pixels and a zoom factor of 2. z line views were obtained by averaging 10 
sections over a line at each z position in 1.0 μm steps.   
 
Biotinylation assays 
 ADPKD cells grown in 6-well plates and were treated with 3 X 10-9 M 
ouabain for 24h. Cells were treated with 0.75 mg/ml Biotin in 1 ml of PBS, pH 8.0 
and incubated for 30 minutes at 4°C. After washing with PBS and 100 mM glycine, 
cells were lysed in RIPA buffer. The soluble supernatants were isolated after 3 min 
centrifugation at 2,000 x g. Then, streptavidin coated magnetic beads were added and 
samples were incubated overnight at 4 °C. Samples were finally washed and 
subjected to SDS-PAGE and immunoblot for detection of the Na,K-ATPase α and β 
subunit. 
 
Data analysis  
Statistical significance of the differences between ouabain treated and untreated 
controls was determined by one way analysis of variance (ANOVA), followed by 
Student’s T test. Statistical significance was defined as P< 0.05. 
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RESULTS 
Ouabain-stimulated proliferation in ADPKD cells requires activation of Src kinase 
and EGFR 
 In a previous report, we have shown that physiological concentrations of 
ouabain, acting through the Na,K-ATPase stimulates the proliferation of ADPKD 
cells as determined by an increase in the mitotic index and number of cells [15].   In 
other cell types, ouabain binding to the Na,K-ATPase has been shown to trigger a 
cascade of intracellular phosphorylating events [2, 10, 14, 16, 31].  Although the 
Na,K-ATPase has no intrinsic kinase activity, its coupling with Src family of 
kinases converts it into a functional receptor tyrosine kinase that operates in a 
manner similar to the classical receptor tyrosine activators.  Ouabain-induced 
stimulation of Src induces secondary tyrosine phosphorylation of a number of 
proteins, including EGFR.  To investigate if ouabain enhancement of growth in 
ADPKD involves the EGFR and Src, we determined whether the proliferation of 
ADPKD cells induced by ouabain is sensitive to inhibitors of the kinase and EGFR.  
For this, cells were treated in the absence and presence of 3 x 10-9 M ouabain for 30 
min, and with the Src kinase inhibitor PP2 (4-amino-5-(4-chlorophenyl)-7-(t-
butyl)pyrazolo[3,4-d]pyrimidine), or the EGFR blocker tyrphostin AG1478.  The 
mentioned amounts and incubation time with ouabain were previously described to 
result in maximal effect in the cells [15].  As shown in Figure 1, the ouabain-
induced growth of the cells, measured using the CellTiter 96 MTT Assay, was 
blocked by inhibition of Src or EGFR.  
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Ouabain stimulates phosphorylation of Src kinase and EGFR in ADPKD cells 
 Because activation of Src and EGFR requires the incorporation of phosphate 
to the proteins [32], we determined the effect of ouabain in inducing 
phosphorylation of Src and EGFR in ADPKD cells.  For this, the levels of 
phosphorylated Src and EGFR were measured in ADPKD cells treated in the 
absence and presence of 3 x 10-9 M ouabain, and without or with PP2 and tyrphostin 
AG1478.  Western blot analyses of cell lysates were performed using antibodies 
specific to each form of the polypeptides.  Figures 2A and 2B present the 
phosphorylated Src (P-Src) and EGFR (P-EGFR) to total Src and EGFR ratios 
respectively for ADPKD cells.  Consistent with an involvement of Src and EGFR in 
Na,K-ATPase signaling in ADPKD cells, phosphorylated levels of both 
polypeptides was significantly increased in the presence of ouabain (Figures 2A and 
2B, respectively).  Moreover, as shown in Figures 2A and 2B, treatment of the cells 
with PP2 and tyrphostin AG1478 abrogated the ouabain-dependent phosphorylation 
of Src and EGFR.  These results demonstrate that the kinase Src and EGFR are 
intermediaries in the Na,K-ATPase signaling cascade that transduces the 
proliferative effects of ouabain in ADPKD cells. 
 Ouabain has also been shown to regulate the interaction between the Na,K-
ATPase and EGFR in epithelial cells [1, 2, 13, 14, 16]. We have explored whether 
activation of EGFR by ouabain requires association of the Na,K-ATPase with the 
polypeptide in ADPKD cells. This was assessed by immunoprecipitation assays.  
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Thus, cells treated without and with 3 x 10-9 M ouabain alone, or in the presence of 
PP2 and tyrphostin AG1478.  The cleared lysates were immunoprecipitated with a 
polyclonal antibody against EGFR.  The immunocomplex was subjected to analysis 
by SDS-PAGE and immunoblot to determine the presence of the α subunit of the 
Na,K-ATPase.  As shown in Figure 3, the Na,K-ATPase catalytic polypeptide co-
immunoprecipitates with the EGFR.  Interestingly, the association between both 
polypeptides was enhanced by ouabain, and was reduced by inhibition of Src and 
EGFR.  These results further suggest the involvement of EGFR in Na,K-ATPase 
signaling in ADPKD cells. 
 
Ouabain-Na,K-ATPase signaling in ADPKD cells requires intact cell caveolae 
    Recent studies indicate that two pools of Na,K-ATPase exist in cells. One is 
involved in ion transport and is diffusely distributed across the plasma membrane. 
The other enzyme population is involved in signaling and is confined to cell surface 
caveolae [16].  Within caveolae, the Na,K-ATPase colocalizes with several proteins 
constituting a signaling complex. This complex is embedded in a cholesterol-
containing microdomain or lipid rafts of the plasma membrane [13]. The role of 
caveolae in ouabain effects in ADPKD cells is unknown. To explore this, we 
investigated the dependence of Na,K-ATPase signaling on caveolae by disrupting 
these membrane structures in the cells through cholesterol depletion with (MβCD). 
Cholesterol sequestration with MβCD represents a common tool that has been 
extensively used for the study of the function of cell caveolae [33]. As a first 
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approach, we studied the effect of MβCD on the ouabain-stimulated proliferation of 
ADPKD cells.  Treatment of the ADPKD cells in the culture medium with MβCD 
prevented the increase in cell number caused by ouabain (Figure 4A).  The 
requirement of structurally intact caveolar membrane domains for Na,K-ATPase 
signaling was confirmed by restoring cholesterol to the cells.  Thus, delivery of 
cholesterol reverted the effect of MβCD in ADPKD cell growth (Figure 4A).  In 
addition, and as expected by its effect in cell proliferation, MβCD also interfered with 
the ability of ouabain to induce phosphorylation of ERK in the cells.  Moreover, the 
response of MβCD in ERK activation was counteracted by replenishing cholesterol in 
the culture medium, which resulted in a significant increase in ouabain-induced P-
ERK levels in the cells (Figure 4B).  Another indication that Na,K-ATPase signaling 
requires normal function of cell caveolae was obtained by studying the effect of 
MβCD on the association of the Na,K-ATPase with the EGFR. For this, after 
treatment with ouabain and MβCD, cells were subjected to immunoprecipitation 
assays.  As shown in Figure 4C, cholesterol depletion blocked the ouabain-dependent 
interaction of the Na,K-ATPase α subunit with EGFR. Accordingly, addition of 
cholesterol to the cell culture media was able to offset the effect of MβCD and 
recovered the Na,K-ATPase-EGFR association that ouabain promotes in the cells 
(Fig. 4C). Altogether, these results suggests that the Na,K-ATPase signaling complex 
of ADPKD cells depends on the presence of normal caveolar domains at the plasma 
membrane of the cells. 
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Ouabain promotes phosphorylation of caveolin-1 in ADPKD cells 
 A major component of caveolae are the caveolins, a family of membrane 
associated scaffolding proteins intimately involved in a variety of cellular processes 
including signal transduction, endocytosis and tumorigenesis.  Caveolin-1 in 
particular is important in Na,K-ATPase mediated signaling.  Interestingly, ouabain 
regulates phosphorylation of caveolin-1, which favors Na,K-ATPase-caveolin-1 
interaction and the formation of a Na,K-ATPase-Src-caveolin complex, in what has 
been named the Na,K-ATPase signalosome [2, 16, 34].  To determine whether Na,K-
ATPase signaling complex in ADPKD cells involves caveolin-1, we explored the 
ability of ouabain to stimulate phosphorylation of caveolin-1.  For this, after treatment 
with or without 3 x 10-9 M ouabain, cells were lysed and subjected to immunoblot 
analysis for phosphorylated caveolin-1 (P-Caveolin).  As presented in Figure 5, the 
levels of P-Caveolin, relative to the total caveolin amounts in the cells significantly 
increases after treatment with ouabain.  Interestingly, the ouabain-induced 
incorporation of phosphate into caveolin requires activation of Src and the EGFR. 
Thus, addition of the inhibitors tyrphostin AG1478 and PP2 interfered with P-
Caveolin formation in the cells. This set of experiments highlight the role of caveolae 
in the effects induced by ouabain in ADPKD cells, and suggests a direct involvement 
of caveolin-1 in the process. 
 
Ouabain-Na,K-ATPase signaling of ADPKD cells involve activation of components of 
the MAPK pathway  
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 The downstream effects of ouabain include phosphorylation and subsequent 
activation of multiple kinases.  Notably, physiological levels of the hormone have 
been shown to stimulate ERK1/2, the final in a series of serine/threonine kinases in 
the MAPK cascade, leading to cell growth.  In ADPKD, the effect of factors known 
to increase cell proliferation, such as EGF and adenylyl cyclase agonists, have been 
shown to converge on activation of the MEK/ERK pathway [26, 27, 35].  Several 
protein kinases are capable of activating the MAPK kinase MEK, including the Raf 
proteins, A-Raf, B-Raf, and c-Raf-1.  While c-Raf-1 is ubiquitously expressed in most 
cells, A-Raf and B-Raf are more restricted [36].  Interestingly, B-Raf is highly 
restricted to the cerebrum and testes, and has been found to be abnormally expressed 
in many types of cancer cells as well as ADPKD epithelial cells [26].  Furthermore, 
cAMP-dependent-PKA activation of B-Raf has been demonstrated as an important 
mediator that functions upstream of the MEK/ERK pathway in ADPKD to promote 
proliferation of the cells [26].   
 To investigate the role of B-Raf in ouabain-induced signaling, ADPKD cells 
were treated with or without ouabain in the presence and absence of tyrphostin 
AG1478 and PP2.  Phosphorylation of B-Raf was determined by Western blot and 
immunofluorescence analysis.  As shown in Figure 6A, ouabain stimulated the 
incorporation of phosphate into B-Raf at Thr598/Ser601, detected equally as bands at 60 
kDa and 90 kDa.  As expected, blockage of Src and EGFR, which are essential for 
Na,K-ATPase signaling, precluded B-Raf activation in the cells.  Likewise, labeling 
of ADPKD cells for phosphorylated B-Raf following experimental treatment revealed 
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an increase in fluorescence when ADPKD cells were exposed to ouabain; the signal 
was noticeably diminished when EGFR and Src activity were inhibited (Figure 6B).  
Altogether, these results suggest the importance of B-Raf as a mediator of ouabain 
induced Na,K-ATPase signaling in ADPKD cells. 
 A key kinase in the ouabain-activated cell pathway is ERK.  Our previous 
observations (see Chapter 2) have shown that the kinase ERK is a mediator of 
ouabain-Na,K-ATPase signaling, and ouabain stimulates phospho-ERK (P-ERK) 
formation in ADPKD cells [15].  Here, we have confirmed this, and as shown in 
Figure 7, addition of the MEK inhibitor U0126 prevents the ouabain-dependent 
phosphorylation of ERK in the cells. Interestingly, when cells were treated with PP2 
and tyrphostin AG1478, phosphorylation of ERK was also inhibited (Figure 7). These 
results are consistent with the effect of these inhibitors on proliferation of ADPKD 
cells and further support the role of ERK in ouabain signaling, suggesting that 
activation of Src and EGFR is an upstream event required for ERK phosphorylation 
in ADPKD cells. 
 Once activated, ERK is capable of translocating to the cell nucleus, where it 
regulates gene expression by stimulating the function of a series of transcription 
factors [37].  To further explore the role of ERK in ouabain signaling, we treated 
ADPKD cells in the absence and presence of ouabain and determined the distribution 
of P-ERK by immunocytochemistry.  Figure 8 shows that ouabain increased the 
levels of P-ERK in the cells.  In addition, P-ERK was found to be present not only at 
the cell cytoplasm, but also in the cell nucleus.  This suggests that ERK is a mediator 
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in the ouabain signal transduction pathway and may be involved in nuclear activation 
of genes responsible for the proliferation of the cells. 
 
Ouabain down-regulates expression of the Na,K-ATPase at the plasma membrane 
 In different receptor-mediated mechanisms, ligand binding results in 
endocytosis and retrieval of the activated receptors from the cell plasma membrane 
[32]. This event is important for controlling receptor signaling levels, availability and 
activation. To determine whether ouabain binding to ADPKD cells results in changes 
of the Na,K-ATPase at the plasma membrane, we performed biotinylation assays. 
Thus, cells treated with or without 3 x 10-9 M ouabain for 24 hours were incubated 
with biotin. Then, total cell surface proteins were immunoprecipitated with 
streptavidin coated magnetic beads, and the samples were subjected to immunoblot 
for identification of the α and β subunits of the Na,K-ATPase.   In this manner, 
changes in Na,K-ATPase polypeptide levels at the plasma membrane of the cells 
could be followed. As shown in Figure 9A, ouabain caused a decrease of the α and β 
polypeptides of the Na,K-ATPase at the surface of ADPKD cells. 
 In agreement with these results, immunocytochemical analysis showed that in 
the absence of ouabain, ADPKD cells shows a typical plasma membrane distribution.  
In contrast, when the cells are exposed to ouabain, label for the Na,K-ATPase is not 
limited strictly to the cell surface, but becomes more diffusely distributed into the cell 
cytoplasm (Figure 9B).  These results suggest that, as occurs with tyrosine kinase 
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receptors, the Na,K-ATPase of ADPKD cells undergoes endocytosis after binding to 
its natural ligand, ouabain [32].  
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DISCUSSION 
  Abnormal proliferation of the renal epithelium is a key component in cyst 
formation and enlargement in ADPKD [19-21, 38, 39].  As the disease progresses, the 
cysts expand due to both fluid secretion into the cyst cavity, and proliferation of the 
cells lining the cyst walls.  In ADPKD, the MEK-ERK pathway has been shown to be 
activated by several mitogenic agents, including growth factors and cAMP agonists, 
resulting in increased cell numbers [24, 40-42].  We have found that ouabain, at low 
concentrations such as those found in the circulation, is an additional factor with a 
positive effect on proliferation of ADPKD cells.   
 In this work, we have characterized the events involved in ouabain-Na,K-
ATPase signaling in ADPKD cells.  We show that integrity of cell caveolae and 
phosphorylation of caveolin-1 is required for stimulation by ouabain in the cells.  This 
agrees with the notion that there is a specific population of the Na,K-ATPase in these 
cells that constitutes the caveolar signalosome.  We also show that upon ouabain 
treatment of ADPKD cells, both EGFR and Src are activated, and association of the 
Na,K-ATPase with the EGFR is promoted.  This agrees with previous observations in 
other cell types.  Activation of the EGFR induces autophosphorylation and 
dimerization of the receptor, and triggers a multitude of intracellular responses, 
including the MAP kinase cascade [32].  Activation of the EGFR in ADPKD is 
particularly relevant in progression of the disease in a mouse model of ADPKD, 
where inhibition of the EGFR slowed progression of cystic disease  [43].     
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 Our results showing ouabain-dependent phosphorylation of Src kinase 
presents the hormone as a factor that stimulates signaling pathways that are common 
to those activated by other ligands known to induce to cell proliferation in ADPKD.  
Increases in Src activity have been found to correlate with increasing severity of 
cystic disease [44, 45], whereas inhibition of Src kinase has been shown to delay 
progression of cystic kidney disease [44].  Our results show that in ADPKD cells, 
ouabain-induced activation of the EGFR and Src is followed by downstream 
stimulation of the MEK-ERK pathway, an important signaling event in cystic disease 
[37].  
 Epidermal growth factor (EGF) and cAMP have been shown to increase 
proliferation of ADPKD cells via distinct mechanisms that converge on activation of 
the MEK-ERK pathway.  The intermediaries between the growth factor receptor and 
the MEK-ERK pathway include a family of GTPase activating proteins, such as Ras 
and Raf.  EGF-stimulation of ADPKD cells has been shown to activate Ras, which 
directly phosphorylates Raf-1, with subsequent activation of MEK and ERK.  On the 
other hand, cAMP-activation of PKA leads to phosphorylation of B-Raf, directly 
upstream of the MEK-ERK cascade.  The involvement of B-Raf in ADPKD is unique 
in two respects.  First, B-Raf is aberrantly expressed in the cystic renal epithelial cells 
[37].  Secondly, unlike normal cells, a PKA-dependent activation of B-Raf has been 
reported in ADPKD cells [26].  B-Raf can also be activated independently of PKA 
via Src-mediated activation of Rap-1 [46].  Our results show that in ADPKD cells, 
ouabain stimulated EGFR and Src, in the absence of EGF.  In addition, exposure of 
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ADPKD cells to ouabain increased the levels of phosphorylated B-Raf.  Because 
ouabain induced activation of Src, it is possible that it may lead to activation of B-Raf 
via Rap-1.  Importantly, Rap-1 expression and activity has been described in ADPKD 
cells [26].  The expression and heightened sensitivity of B-Raf to activation in 
ADPKD has been shown as an important mechanism leading to increased cell 
growth, and was previously shown to be phosphorylated by cAMP-mediated 
activation of PKA [26, 47].  Thus, ouabain may be an additional effector that 
activates PKA in order to increase P-B-Raf levels in ADPKD cells.  The intracellular 
signals involved in the ouabain stimulation of ADPKD cells are represented in Figure 
10.  At present, we are continuing experiments to more precisely define the 
intracellular events involved in ouabain signaling in ADPKD cells.   
 Our findings showed ouabain-mediated activation of the EGFR in the absence 
of EGF; this presents an alternative mechanism by which this receptor is involved in 
cell proliferation in ADPKD.  In addition, ouabain stimulated interaction of the Na,K-
ATPase with Src and EGFR, in conjunction with activation of B-Raf and the MAPK 
pathway.  This reveals ouabain as a novel factor that activates intracellular signals 
converging on a key pathway to promote cell proliferation in ADPKD.  Furthermore, 
the central role the MEK-ERK pathway plays in proliferation in ADPKD has led to 
suggestion that it be targeted for therapy [37].  Thus, inhibiting the signaling events 
triggered by ouabain may be able to halt or delay progression of the disease.   
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Figure 1.  Mitogenic effect of ouabain on ADPKD cells requires Src and the EGF 
Receptor.  Cells grown in 96-well plates were treated for 24 h with 3 x 10-9 M 
ouabain in the absence and presence of 2 μM Tyrphostin AG1478, an inhibitor of the 
epidermal growth factor receptor protein, or 10 μM PP2, an inhibitor of the Src 
family of protein tyrosine kinases.  ADPKD cells were analyzed for (A) cell 
proliferation after 24 h using the CellTiter 96 MTT Assay. Bars represent the means ± 
SE normalized to the untreated control of  8 experiments in 8 different ADPKD 
kidneys. (B) Levels of phosphorylated ERK after 30 minutes.  Bars represent the 
relative phosphorylated ERK (P-ERK)/total ERK, presented as a ratio of the untreated 
controls of 12 determinations on 8 ADPKD kidneys.  *P<0.001 vs respective 
untreated control, **P<0.001 vs. ouabain treated cells. 
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Figure 2.  Effect of ouabain on tyrosine phosphorylation of Src and the EGFR.  Cells 
were exposed to 3 x 10-9 M ouabain alone or in the presence of AG1478 or PP2 for 30 
minutes.  Lysates from untreated control and treated cells were analyzed by 10% 
SDS-PAGE and immunoblotted with (A) anti-Src-Y418 antibody. Blots were then 
stripped and immunoblotted with anti-Src antibody to insure equal loading. (B) 
Ouabain-induced phosphorylation of EGFR was analyzed by immunoprecipitation of 
lysates with a polyclonal anti-EGFR antibody.  Immunoprecipitates were analyzed by 
8% SDS-PAGE and immunoblotted with anti-phosphotyrosine antibody.  Blots were 
then stripped and immunoblotted with anti-EGFR antibody to insure equal loading.  
Bars represent the relative phosphorylated Src (P-Src)/Total Src or P-EGFR/Total 
EGFR, presented as a ratio of the untreated controls of 4 determinations on 4 ADPKD 
kidneys.  *P<0.001, **P<0.01 vs untreated control. 
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Figure 3.  Interaction of the Na,K-ATPase with EGFR is enhanced by ouabain.  Cells 
were exposed to 3 x 10-9 M ouabain alone or in the presence of AG1478 or PP2 for 30 
minutes.  Lysates from untreated control and treated cells were immunoprecipitated 
with a polyclonal anti-EGFR antibody.  Immunoprecipitates were analyzed by 10% 
SDS-PAGE and immunoblotted with the monoclonal 6F antibody to detect α1 of the 
Na,K-ATPase.  Values are presented as means ± SE of the ratio of the untreated 
controls from 3 determinations on 3 ADPKD kidneys.  *P<0.01 vs untreated control. 
 
 
  - 100 - 
Figure 4 
 
 A
0
20
40
60
80
100
120
140
160
180
%
 C
el
l P
ro
lif
er
at
io
n *
Ouabain
MβCD
Cholesterol
- + +
- + +
- - +B
P-ERK
Total ERK
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
R
el
at
iv
e 
P-
E
R
K
 L
ev
el
s *
Ouabain
MβCD
Cholesterol
+ +
+ +
- +
IP:  EGFR
IB:  Na,K-ATPase
C
R
el
at
iv
e 
N
a,
K
-A
TP
as
e 
Le
ve
ls
0
1
2
3
4
5
*
Na,K-ATPase
Ouabain
MβCD
Cholesterol
+ +
+ +
- +
%
 C
el
l P
ro
lif
er
at
io
n
%
 C
el
l P
ro
lif
er
at
io
n
R
el
at
iv
e 
P-
E
R
K
 L
ev
el
s
R
el
at
iv
e 
P-
E
R
K
 L
ev
el
s
R
el
at
iv
e 
N
a,
K
-A
TP
as
e 
Le
ve
ls
R
el
at
iv
e 
N
a,
K
-A
TP
as
e 
Le
ve
ls
 
  - 101 - 
Figure 4.  The signalosome is essential for ouabain signaling in ADPKD.  Cholesterol 
was depleted from the cultures for 30 min. with 10 mM methyl-β-cyclodextrin at 
37˚C to disrupt caveolae, a critical component to assemble the signalosome.  Cells 
were then washed twice in serum-free media and exposed to 3 x 10-9 M ouabain and 
0.5 mM methyl-β-cyclodextrin to maintain a cholesterol-free environment.  
Alternatively, cholesterol was repleted in the culture media for 1 h at 37˚C and 
subsequently treated with 3 x 10-9 M ouabain for (A) 24 h to analyze ouabain-induced 
proliferation in the absence or presence of caveolae; (B) 30 min. to measure p42/p44 
MAPK activation or (C) 30 min. to analyze association of the Na,K-ATPase with 
EGFR  Bars represent the means ± SE of 3 determinations from 3 ADPKD kidneys.  
* P<0.01 compared to untreated controls and/or cultures where cholesterol is 
depleted. 
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Figure 5 
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Figure 5.  Ouabain stimulates tyrosine phosphorylation at Tyr14 of caveolin-1.  Cells 
were treated with 3 x 10-9 M ouabain for 30 minutes in the absence or presence of the 
EGFR inhibitor, AG1478, or the Src inhibitor, PP2.  Cleared lysates were analyzed by 
15% SDS-PAGE and immunoblotted with a monoclonal anti-caveolin-Y14 antibody.  
The blots were then stripped and re-probed with a polyclonal anti-caveolin antibody.  
Bars represent the relative phosphorylated caveolin-1 (P-Caveolin)/Total Caveolin, 
presented as the mean ± SE of the ratio of the untreated controls from 3 
determinations on 3 ADPKD kidneys. *P<0.01 compared to untreated control. 
 
  
  - 104 - 
Figure 6 
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Figure 6.  Ouabain-mediated activation of B-Raf requires EGFR and Src kinase 
activity.  Cells were treated without and with 3 x 10-9 M ouabain for 30 minutes in the 
absence and presence of AG1478 and PP2.  Phosphorylation of B-Raf in ADPKD 
was determined by (A) immunoblot analysis and (B) immunofluorescence 
microscopy.  Inhibition of EGFR or Src activation blocked recruitment of B-Raf in 
the ouabain signaling cascade in both methods of detection.  Bars represent the 
relative phosphorylated B-Raf (P-B-Raf)/Total B-Raf, presented as the mean ± SE of 
the ratio of the untreated controls from 3 determinations on 3 ADPKD kidneys.  
*P<0.01 compared to untreated control. 
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Figure 7 
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Figure 7.  Ouabain activates ERK via the EGFR-Src-MEK pathway in ADPKD cells.  
Ouabain-dependent ERK phosphorylation requires activation of the EGFR, Src and 
MEK.  Cells were treated for 30 min. without or with 3 x 10-9 M ouabain alone, or 
following inhibition of the EGFR (AG1478), Src (PP2) or MEK (U0126).  The 
phosphorylated and total forms of ERK were determined.  Ouabain stimulated ERK 
activation, and this effect was blocked by inhibition of EGFR, Src or MEK.  Bars 
represent the ratio of phosphorylated ERK (P-ERK)/Total ERK, relative to the 
untreated controls.  Bars represent the mean ± SEM of 12 determinations performed 
on cells obtained from 8 ADPKD kidneys.  *P<0.001 vs untreated control. 
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Figure 8 
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Figure 8.  Ouabain induces ERK activation and translocation to the nucleus.  ADPKD 
cells grown on glass coverslips were treated in the absence and presence of 3 x 10-9 M 
ouabain for 30 min. and labeled with an anti-phospho-ERK antibody, followed by an 
Alexa Fluor 594 secondary antibody.  Cell nuclei were stained with DAPI.  
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Figure 9 
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Figure 9.  Na,K-ATPase expression at the plasma membrane is down-regulated by 
ouabain.  ADPKD cells were treated in the absence and presence of 3 x 10-9 M 
ouabain for 24 h and examined for expression of the Na,K-ATPase by (A) Western 
blot analysis following biotinylation of surface proteins.  Expression of both the α1 
and β1 subunits of the Na,K-ATPase were found to be reduced by ~50% after 
treatment with ouabain for 24 h.  Bars represent the mean ± SEM of 3 determinations 
performed on cells obtained from 3 ADPKD kidneys.  *P<0.01 vs untreated control.  
(B) Immunofluorescence microscopy of confluent cultures grown on filter supports 
treated with ouabain for 24 h and labeled for the α1 subunit of the Na,K-ATPase.  
Top panels show z-line views positioned at the lines indicated in the x-y views shown 
in the bottom panels.  Ap, apical; Bl, basolateral side of the cells. 
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Figure 10 
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Figure 10.  Signaling pathway activated by ouabain in ADPKD.  Ouabain binding to 
the Na,K-ATPase induces phosphorylation and activation of the EGFR and Src 
kinase.  Src, through intermediary steps to be defined, leads to activation of B-Raf, 
MEK and ERK.  Phosphorylated ERK translocates to the nucleus to regulate gene 
expression, leading to increased cell proliferation. 
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CHAPTER 4 
OUABAIN ENHANCES PROGRAMMED CELL DEATH IN ADPKD CELLS 
ABSTRACT 
The progression of autosomal dominant polycystic kidney disease (ADPKD) is 
characterized by increased cell proliferation and apoptosis, or programmed cell death.  
Inhibition of either process reduces cystogenesis and slows progression of the disease.  
Previous work in our laboratory has shown that physiological levels of ouabain 
stimulate proliferation of ADPKD cells via interaction with the Na,K-ATPase and 
subsequent activation of the epidermal growth factor receptor (EGFR), Src kinase, 
and the MAP kinase pathway.  In this work, we found that the same levels of ouabain 
also promote apoptotic death of ADPKD cells, as determined by TUNEL staining, a 
biochemical marker of DNA fragmentation.  In addition, ouabain induced activation 
of caspase-3, a key executioner of the cell apoptotic pathway.  Activation of caspase-
3 was not mediated by ouabain-stimulation of EGFR or Src, suggesting that the 
pathway triggered by ouabain to promote cell proliferation is distinct from the 
pathway that activates apoptosis.  Apoptosis induced by ouabain resulted in release of 
cytochrome c from mitochondria, indicating that the hormone is able to activate the 
intrinsic pathway that leads to programmed cell death.  The dual effect of ouabain in 
cell proliferation and apoptosis of ADPKD cells suggests an important role of the 
hormone in regulating epithelial cell growth, an event that is intimately related to 
progression of the disease. 
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INTRODUCTION 
 Apoptosis is a process of programmed cell death that is tightly regulated 
during normal development and aging, and is critical in maintaining the homeostasis 
of many cell populations [1].  Changes in the rate of apoptosis have been found in 
several pathological situations [1-5].  Autosomal dominant polycystic kidney disease 
(ADPKD) is one of many diseases in which the precise regulation of apoptosis is 
altered [6-8].  One of the characteristics of ADPKD is that the disease progresses 
relatively slowly  throughout the lifetime of the affected individual [9, 10].  This 
characteristic is difficult to explain if increased cell proliferation is the only defect.  
Interestingly, increased rates of apoptosis have been reported in animal models of 
PKD, and in kidneys from humans with ADPKD, and is now recognized as a 
histopathologic feature of the disease [8, 11, 12].  Furthermore, cystogenesis has been 
found to be attenuated when apoptosis is inhibited [13].  It has been proposed that in 
the epithelium of ADPKD cysts, the balance between cell proliferation and death is 
perturbed, and that loss of some tubular cystic cells by apoptosis may stimulate 
proliferation of surrounding cells [8].  Thus, the aberrant increase in programmed cell 
death of the cystic epithelium is a mechanism that influences progression of ADPKD  
[11, 14].  Although apoptosis has been described in ADPKD, further studies are 
required to elucidate the mechanisms by which the process is regulated in cystic cells.  
Understanding the factors influencing ADPKD apoptosis is important since this event 
affects cyst progression. 
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 The mechanisms of apoptosis are complex, involving an intricate cascade of 
molecular events.  A family of cysteine proteases, the caspases, are major mediators 
of the apoptotic process [1].  These include the “initiator” caspases-8, -9 and -10, and 
the “executioner” caspases-3 and -7.  There are two main pathways of caspase-
mediated apoptosis.  The extrinsic pathway involves transmembrane receptor 
mediated interaction, and is characterized by the activation of caspase-8 and -10.  The 
intrinsic pathway is distinguished by the disruption of mitochondrial function, 
allowing the release of pro-apoptotic proteins, such as cytochrome c, from the 
mitochondrial intermembrane to the cytosol.  Here, cytochrome c forms part of a 
complex that includes pro-caspase-9, known as the "apoptosome".  Subsequently, 
pro-caspase-9 is cleaved to its active form.  Both the intrinsic and extrinsic pathways 
converge at this point to stimulate the activities of caspases-3 and -7.  These last 
caspases are responsible for the typical events of apoptosis, including DNA 
fragmentation, protein cross-linking and degradation, and disintegration of the cell 
into apoptotic bodies [4].   
 The Na,K-ATPase is a plasma membrane enzyme essential in maintaining the 
normal gradients of Na+ and K+ in the cell.  While maintenance of cellular ion 
homeostasis by the Na,K-ATPase is critical to cell survival and function, the Na,K-
ATPase also serves as a signal transducer for the effects of the hormone ouabain in 
cells.  Upon ouabain binding to the Na,K-ATPase, multiple intracellular signaling 
events are activated that affect cell growth, survival, differentiation and cell death 
[15].  By acting through the Na,K-ATPase, cardiac glycosides, such as ouabain, have 
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been shown to regulate apoptosis through the Na,K-ATPase in a cell type specific 
fashion [15-19].  In T-cell leukemia, inhibition of the Na,K-ATPase renders the cells 
more susceptible to ligand-induced apoptotic cell death [20].  On the other hand, 
ouabain has been shown to protect human umbilical vein endothelial cells against 
apoptosis [21].  Our previous work has shown that ouabain has a mitogenic effect in 
ADPKD cells.  In this work, we describe that the hormone also enhances apoptosis in 
ADPKD cells.  Because the overall effect of ouabain results in ADPKD cell growth, 
stimulation of cell proliferation must predominate over cell death, suggesting that 
ouabain creates a disbalance in the ADPKD cell growth in favor of proliferation [14]. 
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METHODS 
Cell culture   
 Primary cell cultures derived from surface cysts of ADPKD kidneys (ADPKD 
cells) were generated by the PKD Biomaterial Core at University of Kansas Medical 
Center (KUMC). A protocol for the use of discarded human kidney tissues was 
approved by the Institutional Review Board at KUMC. Primary cultures were 
prepared as described [22]. Cells were seeded and grown in DME/F12 supplemented 
with 1% heat-inactivated fetal bovine serum (FBS), 100 IU/ml penicillin G and 0.1 
mg/ml streptomycin, 5 µg/mL insulin, 5 µg/mL transferrin, and 5 ng/mL sodium 
selenite (ITS).  Twenty-four hours before cells were subjected to experimental 
manipulation, the serum was reduced to 0.002% and ITS was removed.  As 
previously shown, these cells are epithelial in nature and the majority of the cells 
stain positive for specific lectin markers for the collecting duct and distal nephron, 
such as Arachis hypogaea (PNA) and Dolichos biflorus agglutinin (DBA) [23]. This 
suggests that the cultures are enriched in cells derived from distal nephrons and 
collecting tubules.  
 
Measurement of fragmented DNA by TUNEL assay 
 Cells cultured on glass coverslips were treated with ouabain and analyzed for 
apoptosis using the DeadEnd fluorometric TUNEL system (Promega, Madison, WI).  
This method determines nuclear fragmentation, an important biochemical marker for 
cell apoptosis, by using terminal deoxynucleotidyl transferase to transfer fluorescein 
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(FITC)-12-dUTP to the free 3’-OH of cleaved DNA.  The cells are then counter-
stained with DAPI.  The percentage of cells undergoing apoptosis is determined by 
direct visualization with fluorescence microscopy. 
 
Immunoblot analysis for activated caspase-3 
 Cells treated without and with ouabain for 24 h were washed once with ice-
cold PBS and lysed with buffer containing 10 mM Tris-Cl (pH 7.4), 10 mM NaCl, 3 
mM MgCl2, 0.1% NP-40.  50 μg of the cleared lysates were analyzed by 15% SDS-
PAGE and blotted onto nitrocellulose membranes.  The immunoblots were probed 
with an antibody that simultaneously recognizes the inactive pro-form and the active 
cleaved forms of caspase-3 (Cell Signaling Technology, Boston, MA).   
 
Analysis of cytochrome c translocation 
 Cells treated without and with ouabain for 24 h were washed with ice-cold 
PBS and fractionated into mitochondrial and cytosolic proteins using the Active 
Motif Mitochondrial Fractionation Kit according to manufacturer's recommendations 
(Active Motif, Carlsbad, CA).  Briefly, cells were collected and disrupted by glass-
homogenization (40 strokes).  The supernatant containing the cytosolic and 
mitochondrial proteins were separated by centrifugation at 800xg for 20 min at 4˚C.  
The cytosolic fraction contained in the supernatant was separated by centrifugation at 
10,000xg for 20 min at 4˚C, and further cleared by centrifugation at 16,000xg for 20 
min at 4˚C.  The mitochondrial proteins were lysed and resuspended in Complete 
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Mitochondrial Buffer.  The fractions were analyzed by 15% SDS-PAGE and blotted 
onto nitrocellulose membranes.  The immunoblots were probed with a monoclonal 
antibody against cytochrome c (BD Pharmingen, San Diego, CA). 
 
Measurement of caspase-3/7 activity 
 Caspase-3/7 activity was determined using the Caspase-Glo 3/7 Assay 
according to manufacturer's instructions (Promega, Madison, WI).  Briefly, cells were 
seeded into black-walled, clear-bottomed 96-well plates (Corning Inc., Corning, NY) 
at a density of 4000 cells per well and treated without or with ouabain in the presence 
and absence of tyrphostin AG1478 and PP2, inhibitors of the EGFR and Src, 
respectively.  The luminogenic caspase-3/7 substrate was added; any active caspase-3 
or -7 would cleave this substrate and release the luminescent signal that is 
proportional to the amount of caspase activity present.  The data are expressed as a 
percentage of untreated controls. 
 
Data analysis 
 Statistical significance of the differences between ouabain treated and 
untreated controls was determined by one way analysis of variance (ANOVA), 
followed by Student’s T test. Statistical significance was defined as P< 0.05. 
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RESULTS 
Ouabain stimulates apoptotic death of ADPKD cells. 
Ouabain has been shown to stimulate apoptosis in several cell types [16, 17, 
24, 25].  To establish whether ouabain influences apoptosis in ADPKD cells, we 
treated the cystic cells without and with 3 x 10-9 M ouabain and explored DNA 
nuclear fragmentation, an important biochemical marker for cell apoptosis.  For this, 
cells were subjected to TUNEL assays.  As shown in Figure 1, ouabain induced the 
DNA of ADPKD cells to degrade into multiple nucleosomal units.  The apoptotic 
effect of ouabain was abolished by the general caspase inhibitor, carbobenzoxy-valyl-
alanyl-aspartyl-[O-methyl]-fluoro-methylketone (z-VAD-fmk).  This suggests that 
the hormone specifically induced programmed cell death that is mediated via 
caspases. 
Ouabain-induced apoptosis in ADPKD cells was also revealed by following 
the cleavage of caspase-3.  Activation of caspase-3 requires proteolytic cleavage of 
the inactive 35 kDa zymogen into the active p17 and p12 subunits.   As shown in 
Figure 2, and as detected by immunoblot analysis with anti-caspase-3 antibodies, 
addition of 3 x 10-9 M ouabain to the ADPKD cell cultures resulted in cleavage of the 
inactive, full length, pro-caspase-3 into its active large and small fragments.   
To more directly assess the activation of caspase in ADPKD cells, functional 
caspase levels were determined using the Caspase-3/7 Glo Assay (Promega).  As 
shown in Figure 3, cells treated with ouabain had a significantly higher level of 
caspase-3/7 activity than untreated cells.  Moreover, inhibition of EGFR or Src with 
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tyrphostin AG1478 or PP2 respectively, further enhanced caspase-3/7 activity.  
Collectively, these results indicate that ouabain-induced apoptosis in ADPKD cells is 
independent of stimulation of the EGF receptor and Src.  Because these signaling 
molecules are important in ouabain-induced cell growth, these data show that the 
apoptotic pathways induced by the hormone are separate from those that stimulate 
cell proliferation.  Thus, although ouabain has a dual role in proliferation and 
apoptosis, the intracellular mechanisms for each effect are distinct.   
 
Ouabain activates the intrinsic pathway of apoptosis 
Caspase-3 is one of the final enzymes responsible for directing the cell 
towards self-destruction, and is the point where the intrinsic and extrinsic pathways of 
apoptosis converge.  One event that distinguishes which of the two pathways is active 
in cells is the release of cytochrome c from mitochondria.  Presence of cytochrome c 
in the cell cytoplasm is characteristic of activation of the intrinsic pathway of cell 
apoptosis.  To further delineate which of the mechanisms of cell death are induced by 
ouabain, we examined localization of cytochrome c in ADPKD cells after treatment 
in the absence and presence of 3 x 10-9 M ouabain.  As shown in Figure 4, analysis of 
mitochondrial and cytoplasmic fractions from the cells by immunoblot, using an 
antibody for cytochrome c, revealed that some basal levels of cytochrome c are found 
in the cytoplasm of the untreated cells.  Interestingly, ouabain treatment significantly 
increased the amounts of cytochrome c in the cytoplasmic fraction of ADPKD cells 
over basal levels.  These results indicate that the effect of ouabain in apoptotic death 
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of ADPKD cells is through activation of the intrinsic pathway of programmed cell 
death. 
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DISCUSSION 
 
 Precise control of programmed cell death plays a critical role in the cellular 
life cycle.  Defects in regulation of apoptosis can have dramatic consequences.  While 
an increase in apoptosis could lead to degenerative autoimmune disorders, down-
regulation of the process results in hyperproliferative  diseases such as cancer [1].  
The pathogenesis of ADPKD is believed to involve a paradoxical increase in both cell 
proliferation and apoptosis, and both processes are required for cystogenesis and 
progression of the disease [7, 8, 13, 14, 26-30].  Because apoptosis is increased in all 
nephron segments of the cystic kidneys, but is absent in tubules from non-PKD end-
stage renal disease patients, it has been suggested that the apoptotic loss of renal 
tissue correlates with the progressive loss of renal function in PKD [30].     
 Epithelial cells cultured from polycystic kidneys have been shown to retain 
their apoptotic capacity, providing a valuable tool to study the mechanisms 
underlying the aberrant increase in cell death in ADPKD [30].  Previous work from 
our laboratory has shown physiological levels of ouabain to induce proliferation of 
ADPKD cells, activating the EGFR-Src and MAP kinase pathway [31, 32].  In this 
work, we show that in addition to a mitogenic effect, the same concentration of 
ouabain promotes ADPKD cells to undergo apoptosis.  The mechanism of ouabain-
stimulated cell death was independent from activation of EGFR and Src.  Increased 
cell growth and apoptosis are pathological features of ADPKD.  While activation of 
the MAP kinase pathway has been identified to be a key pathway of ADPKD cell 
proliferation, and has been pharmacologically targeted in an attempt to treat the 
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disease [33], the mechanisms underlying increased apoptosis are less clear.  Here, we 
show that ouabain stimulates apoptosis via activation of the intrinsic pathway, 
through the release of cytochrome c from the mitochondria and the subsequent 
activation of caspase-3.  This suggests that in ADPKD cells, ouabain functions in a 
manner similar to that of agents that induce stress in cells. 
 Our results concur with studies in a rodent model of ADPKD, the Han:SPRD 
rat, which revealed that the intrinsic pathway is involved in the increased 
programmed cell death that underlies the pathophysiology of the disease [11, 34].  
Similar to our findings, Han:SPRD rats show increased levels of cytochrome c in the 
cytoplasm of the kidney cells. Release of cytochrome c into the cytoplasm is triggered 
by a variety of factors, including DNA damage, loss of cell-cell contact, deprivation 
of growth factors or serum from the culture media, presence of toxins, hypoxia, 
hyperthermia and the increase in free radicals [1, 35].  Ouabain has been shown to 
stimulate mitochondrial production of reactive oxygen species (ROS) in rat cardiac 
myocytes [36, 37].  Increases in ROS from the mitochondria can lead to damage of 
the mitochondrial membrane potential and integrity, allowing further release of 
cytochrome c into the cell cytoplasm. In this manner, ROS acts as a signal that 
amplifies activation of the intrinsic pathway of apoptosis to produce full activation of 
caspase-3 [38].  Further studies will be required to identify whether ROS is an 
intermediary in the intracellular cascade of events for ouabain-mediated apoptosis in 
ADPKD cells. 
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 Our results also show that the pathways mediating the proliferative and 
apoptotic effects of ouabain in ADPKD cells are distinct.  While ouabain-induced cell 
growth depends on activation of  EGFR, Src and the MAP kinase pathway, the 
apoptotic effect is independent of these intracellular effectors.  Rather, ouabain-
induced cell death is mediated via activation of the intrinsic pathway of caspase-
mediated apoptosis.  Inhibition of the ouabain-induced pathways of cell proliferation 
with blockers of the EGFR or Src resulted in an increase in caspase-3/7 activity in 
ADPKD cells that is higher than that obtained when the cells were treated with 
ouabain alone.  This suggests that the mitogenic effects of ouabain, mediated through 
EGFR and Src, predominate over the apoptotic effect that is mediated via  the 
intrinsic pathway of cell death. Therefore, ouabain appears to cause an imbalance 
between cell proliferation and death in ADPKD cells to favor cell growth. The 
capacity of ouabain to increase both proliferation and apoptosis in ADPKD cells 
presents this hormone as an important factor that can contribute in sustaining the 
pathophysiology of the disease.  Thus, future efforts could be directed to interfere 
with ouabain signaling events as an effort to attenuate renal cystic disease.   
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Figure 1 
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Figure 1.  Ouabain induces DNA fragmentation in ADPKD cells.  Cells seeded onto 
glass coverslips were subjected to experimental conditions for 24 h, then fixed in 10% 
buffered formalin.  Using the DeadEnd Fluorometric TUNEL System (Promega, 
Madison, WI), fragmented DNA was labeled by incorporation of fluorescein-12-
dUTP(a) at 3'-OH DNA ends.  The nuclei were counterstained with DAPI and 
visualized by immunofluorescence microscopy.  As a positive control, cells were 
treated with camptothecin.  At least 10 random fields were analyzed from three 
different ADPKD kidneys.  Bars represent the percentage of green fluorescent cells 
relative to the total cells per unit area.  * P < 0.05 versus untreated control. 
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Figure 2 
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Figure 2.  Caspase-3 is cleaved from its inactive pro-form into its active subunits in 
ADPKD after ouabain treatment.   Activation of caspase-3 requires proteolytic 
cleavage of its inactive zymogen, detected as a 35 kDa band, into its active p17 and 
p12 subunits, detected at 17 and 19 kDa.  ADPKD cells exposed to 3 x 10-9 M 
ouabain induced activation of caspase-3, while culture media alone had no effect.  As 
a positive control, Jurkat cells were treated with etoposide.   
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Figure 3 
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Figure 3.  Ouabain-mediated increase in caspase-3/7 activity is independent of the 
EGFR and Src.  Activity levels of caspase-3 and -7 were measured, using the 
Caspase-3/7 Glo Assay (Promega, Madison, WI) in cells treated without and with 3 x 
10-9 M ouabain in the absence and presence of tyrphostin AG1478 and PP2, inhibitors 
of the EGFR and Src, respectively.  Caspase-3 and -7 have identical peptide 
sequences that are cleaved upon activation, and are thus, measured simultaneously in 
this assay.  Ouabain-stimulated increases in caspase activity were exacerbated when 
EGFR or Src were inhibited.  Data are means ± SE of 6 determinations on 6 different 
ADPKD kidneys.  * P < 0.05 
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Figure 4 
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Figure 4.  Ouabain stimulated translocation of cytochrome c from the mitochondria to 
the cytoplasm in ADPKD.  Cytochrome c release from mitochondria results from an 
insult to the cell, activating the intrinsic pathway of apoptosis.  Following treatment 
with 3 x 10-9 M ouabain, ADPKD cells were fractionated into the cytosolic and 
mitochondrial proteins.  While a small amount of cytochrome c is observed in the 
cytosol of untreated cells, there is an increase after exposure to ouabain.  In the 
mitochondria, the levels of cytochrome c are diminished following ouabain treatment, 
in agreement with movement of the protein into cytosol.  In untreated cells, there is 
no difference in expression levels of cytochrome c in either compartment. 
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CHAPTER 5 
OUABAIN INFLUENCES THE DEVELOPMENT OF ADPKD CYSTS 
ABSTRACT 
 In autosomal dominant polycystic kidney disease (ADPKD), renal 
cystogenesis requires increased proliferation of the nephron tubular cells in 
conjunction with sustained fluid secretion through the kidney epithelium.  Salt and 
water secretion are critical events in the expansion and successive enlargement of the 
cyst cavity.  Several agents, such as cAMP have been identified as stimulators of fluid 
secretion in ADPKD, thus, accelerating the progression of the disease.  We have 
previously shown that ouabain significantly increases proliferation of ADPKD cells.  
The effect is mediated through a population of the Na,K-ATPase that has an 
abnormally high affinity for ouabain.  In this work, we have explored whether 
ouabain can also influence the formation and enlargement of renal cysts.  For this, we 
have determined the effect of ouabain on microcysts of ADPKD cells grown in three 
dimensional collagen matrix cultures, and in metanephric organ cultures from wild 
type, Pkd1m1Bei heterozygous and homozygous mice, a well characterized model of 
ADPKD.  We demonstrate that in both systems, ouabain in concentrations similar to 
those circulating in blood, has no significant effect on cyst size.  However, when used 
in combination with conditions that increase intracellular cAMP, such as forskolin 
and 8-Br-cAMP, ouabain significantly enhanced the number and size of ADPKD 
microcysts, and increased the fractional cyst area of the metanephric organ cultures.  
This effect of ouabain is mediated through activation of the mitogen extracellular 
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kinase, MEK, indicating that it depends on the ability of the Na,K-ATPase to function 
as a signaling molecule that activates intracellular events in the cells.  These results 
show that ouabain can act as a cofactor that enhances fluid secretion by the renal 
cystic epithelium, and provides further evidence for the role of ouabain as an agent 
with positive effects on the progression of ADPKD.   
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INTRODUCTION 
 Polycystic kidney disease (PKD) includes a group of renal diseases with a 
common pathogenesis characterized by the development of numerous cysts that 
abnormally emerge from different regions of the nephron.  In autosomal dominant 
polycystic kidney disease (ADPKD), the cysts grow over a period of years, distorting 
the structure of the renal parenchyma, and slowly impairing kidney function to 
eventually cause renal failure [1-4].  Approximately one half of ADPKD patients 
require dialysis or kidney replacement by the age of 60, and ADPKD is responsible 
for approximately 8-10% of all cases of end-stage renal failure [5-8].  Studies in 
ADPKD patients and a variety of experimental models of the disease implicate two 
major factors in the formation and maintenance of renal cysts.  One is the abnormal 
proliferation or hyperplasia of the tubular cells; the second is the change in the salt 
and fluid transport properties of the renal epithelium, which modifies its reabsorptive 
capacity to favor secretion of fluid into the lumen of the vesicles [9, 10].  The initial 
event in kidney cystogenesis is the augmented cell growth, which leads to focal 
expansions of the tubular epithelium into “blister like” structures.  As they progress, 
these structures increase in size, eventually losing contact with the nephron that 
originated them.  Cysts then continue to expand as isolated fluid-filled sacs, 
increasing their size through the combined effect of cell proliferation and continuous 
fluid secretion into the growing cyst cavity.  Therefore, fluid secretion plays an 
essential role in maintaining the shape and turgidity of the cysts. 
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Although the renal epithelium has been shown to secrete fluid to some extent 
under physiological conditions, this process is highly enhanced in ADPKD [11].  The 
driving force for fluid secretion in cultured epithelial cells from cysts of ADPKD 
kidneys is the adenosine 3',5'-cyclic monophosphate (cAMP)-dependent 
transepithelial transport of Cl-  [9].  This is mediated through the cystic fibrosis 
transmembrane conductance regulator (CFTR), present at the apical surface of cyst-
lining epithelial cells.  In this manner, cAMP has been shown as one of the principal 
humoral factors that stimulates fluid secretion in ADPKD [9, 12-16]. 
The molecular bases responsible for fluid secretion in ADPKD have been 
defined through the use of several in vitro approaches.  For example, a useful and 
well-characterized model is the three dimensional collagen matrix culture, in which 
suspended ADPKD cells are capable of forming microcysts.  Essential to the cultures 
is the addition of adenylyl cyclase agonists, such as forskolin, which induces the 
production of cAMP and enhances proliferation and fluid secretion of the cultured 
cells, thereby forming microcysts [17, 18].  Similar to the native renal cysts, the 
microcysts formed under collagen cultures are constituted by a single layer of cells 
that preserve their polarized properties, with the basolateral domain of the cells in 
contact with the collagen matrix and the luminal side facing the cyst cavity.  Another 
approach that has been instrumental in studying the pathophysiology of ADPKD cyst 
development is the use of  metanephric organ cultures [11, 19-21].  Cultured 
metanephric kidneys are largely avascular and do not support glomerular filtration.  
Therefore, fluid accumulation in the developing tubules derives solely from its 
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transport across the tubular epithelium [19].  Metanephric cultures of  Pkd1m1Bei 
homozygous mice carry a point mutation on the Pkd1 gene, express a functionally 
null polycystin-1 protein, exhibit massive renal cysts by day 18.5 in culture, and die 
in utero [22]. This mouse model has helped in understanding the role of cAMP and 
requirement of the CFTR in ADPKD cystogenesis. 
 In addition to cAMP, other circulating factors have been found to influence 
cyst growth in ADPKD.  Understanding the factors involved in cyst development and 
progression, and their molecular mechanisms of action are essential goals in 
predicting the outcome of ADPKD, as well as in finding therapeutic methods to treat 
the disease.   
We have previously shown that ouabain, a well characterized hormone that 
circulates in plasma of mammals, stimulates proliferation of epithelial cells from 
kidneys of patients with ADPKD.  Ouabain exerts its effect by binding to its receptor, 
the Na,K-ATPase, which initiates a cascade of signaling events in the cells [23].  
Interestingly, ADPKD cells have an abnormally high response to ouabain, and 
approximately 20% of the Na,K-ATPase expressed in the cells is sensitive to 
physiological concentrations of ouabain [24].  While the peculiar response of the 
Na,K-ATPase to ouabain is responsible for the proliferation of ADPKD cells, the 
effect of ouabain on the secretory function of the cells is unknown.  Previous work 
has demonstrated that complete inhibition of activity of the Na,K-ATPase with 
ouabain totally abolishes fluid secretion in the ADPKD epithelium [10, 16].  
However, the consequences of physiological levels of ouabain on the fluid transport 
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properties of ADPKD cells have not yet been evaluated.  Our previous results have 
shown that in addition to being an ion transporter, the Na,K-ATPase of ADPKD cells 
functions as a signaling molecule to transmit ouabain effects into the cells [24].  
Interestingly, we have shown that ouabain-Na,K-ATPase signaling in ADPKD cells 
includes the activation of the extracellular regulated kinase, MEK.  This pathway has 
been implicated in the increased production of cAMP that drives fluid secretion in 
ADPKD cells [25-28].  These results suggest that ouabain may act as a factor that 
contributes to cyst enlargement, not only by promoting cell growth, but also by 
enhancing fluid secretion through the ADPKD epithelium.  In this work, we have 
explored the effects of physiological levels of ouabain in cyst development of 
microcysts cultures of ADPKD cells and in metanephric organ cultures of Pkd1m1Bei 
mice.  Our results show that ouabain acts as a co-factor that contributes to the 
formation and expansion of renal ADPKD cysts.  This further supports the role of 
ouabain as an agent that exacerbates progression of ADPKD.  
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METHODS 
Microcyst cultures in hydrated collagen gels 
 Cystic cells were suspended at a density of 4000 cells per well in a 96-well 
plate in ice cold type I collagen (Vitrogen) in Defined Medium that does not stimulate 
cyst growth, comprised of 1:1 DME/F12, 100U/ml penicillin, 0.1mg/mL 
streptomycin,  ITS, 5x10-8 M hydrocortisone and 5x10-8 M triiodothyronine.  After 
the cells/collagen suspension were seeded, the gel was polymerized by warming to 
37°C.  To determine if ouabain alone could induce cyst formation and growth, 
Defined Medium containing 3 nM ouabain was used to hydrate the gels and cells 
were examined daily by phase microscopy for cyst growth.  To determine if ouabain 
acts as an agonist to cyst growth, cysts were induced to grow by pre-treatment for 2-4 
days with 5 µM forskolin and 5 ng/mL EGF.  Once the cysts reached 100 µm in 
diameter, EGF was removed and treated either with experimental media: 5 μM 
forskolin alone; 3 x 10-9 M ouabain alone; ouabain + forskolin; 1 μM U0126; 
forskolin + U0126; ouabain + forskolin + U0126.  After 5-7 days in culture in which 
the cysts were allowed to grow without overlapping, they were fixed with 1% 
formalin in PBS and analyzed by the analySIS software (Lakewood, CO) to count and 
measure cysts exceeding 100 μm in diameter.  The average total surface area 
represents only those cysts that increased in size with experimental treatments. 
 
Embryonic organ cultures 
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 Pkd1m1Bei mice obtained from the Mutant Mouse Regional Resource Center 
(University of North Carolina, Chapel Hill, NC) [22] were stabilized onto a C57BL/6 
background [11].  Mice heterozygous for Pkd1 were mated.  Embryos from timed-
pregnant females at embryonic day 15.5 (E15.5) were extracted.  One front paw was 
removed and used to extract DNA to genotype each embryo.  Under sterile 
conditions, metanephric kidneys were dissected and transferred to transwell filters 
(0.4 µm pore size; BD Biosciences, San Jose, CA) in a six-well culture plate.  
Metanephroi were cultured at an air-fluid interface with serum-free medium 
containing equal volumes of DME/F12 supplemented with 2mM L-glutamine, 10 
mM HEPES, ITS, 25 ng/mL prostaglandin E1, 32 pg/mL T3, and P/S.  The media was 
supplemented with reagents (100 μM 8-Br-cAMP and/or 3 x 10-8 M ouabain) and 
added to the lower chamber of the culture inserts.  Kidneys were refreshed daily and 
maintained at 37°C in a humidified chamber containing 5% CO2 and 95% air.  
Kidneys were observed by phase contrast microscopy and images captured at 2, 3, 4, 
and 5 days.   
 
Quantification of dilated tubule area 
Quantification was performed on captured images using analySIS software as 
previously described [11].  Total kidney area was measured using the freehand 
polygon tool to trace the perimeter of the kidney, excluding the ureter.  Cyst area was 
determined using the wand tool.  A pixel was selected within a dilated tubule, which 
would automatically select all pixels of similar density.  When all dilated tubules 
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were selected, the area was calculated by the software.  Fractional cyst area was 
calculated as total dilated tubule area divided by total kidney area.  
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RESULTS 
Ouabain increases microcyst number and size in ADPKD cultures 
 When cultured in a three dimensional matrix of polymerized collagen, 
ADPKD cells have been shown to form microcysts by clonal expansion of single 
cells with proper stimulation [16].  In these kind of cultures, the cells develop an 
epithelial monolayer of cells that preserves the polarized vectorial movement of salt 
and water that is typical of the wall surrounding the ADPKD cysts.  Epidermal 
growth factor (EGF) is an essential requirement for the initiation of microcyst 
formation of these cultures, and activation of adenylyl cyclase, through agents such as 
forskolin, is necessary to induce fluid secretion by the epithelium [10, 16].   
 We have used this in vitro model to study the effect of ouabain on fluid 
secretion by the ADPKD epithelium.  ADPKD cells in collagen matrices were 
stimulated to form microcysts with EGF and forskolin.  Once the cysts reached a size 
of 100 µm in diameter, EGF was removed from the medium and cultures were 
maintained under a variety of conditions for further analysis of microcyst growth and 
enlargement.  Changes in cyst size were quantified and expressed as the average total 
surface area of cysts larger than 100 μm in diameter and is summarized in Figure 1E.   
 Once the development of the microcysts was initiated, removal of EGF and 
forskolin from the culture media stopped further growth of the microcysts (Figure 
1A).  This experimental condition served as a control to further study the effect of 
ouabain on cyst progression. As previously reported, the addition of forskolin after 
EGF treatment caused a significant increase in microcyst growth (Figure 1B).  This 
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confirmed the importance of EGF as an initiator of the process, and that activation of 
adenylate cyclase with forskolin alone is  sufficient to stimulate ADPKD fluid 
secretion [10, 16].  Treatment of the cultures with only 3 x 10-9 M ouabain after EGF 
did not result in significant changes in cyst size (Figure 1C).  Interestingly, however, 
when the pre-formed microcysts were simultaneously exposed to ouabain and 
forskolin, there was an increase in the size and number of cysts that was significantly 
higher than that observed with just forskolin alone (Figure 1D). These results 
support the idea that ouabain functions as a co-factor important for the enhancement 
of cyst growth.   
 We have previously shown that ouabain exerts a stimulatory effect on 
ADPKD cell proliferation, and that the mechanism of this effect depends on 
activation of the regulated mitogen kinase MEK.  To explore whether ouabain-
induced exacerbation of cyst formation involves activation of the mitogen activated 
protein kinase pathway (MAPK) in the cells, we determine the effect of MEK 
inhibition on the ouabain-dependent progression of ADPKD microcysts.  For this, 
microcysts were initiated with EGF, and were subsequently stimulated with ouabain 
and forskolin in the presence of the MEK inhibitor, U0126.  As shown in Figure 1E, 
U0126 did not induce changes in the non-stimulated cultures.  Inhibition of MEK also 
had no effect on forskolin-induced growth in the cysts.  In contrast, blocking MEK 
prevented the ability of ouabain to exacerbate microcyst growth.  Altogether, these 
results suggest that the stimulatory effect of ouabain on cyst formation and expansion 
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by the ADPKD epithelium requires activation of the MAPK pathway component, 
MEK.  
 
Ouabain exacerbates cAMP-induced cystic progression in metanephric organ 
cultures 
 Metanephric organ cultures of Pkd1m1Bei mice have been instrumental in the 
study of the mechanisms governing salt and water transport in ADPKD.  Segment-
specific lectin staining of sectioned metanephroi after treatment with 8-Br-cAMP for 
the collecting duct with Dolichos biflorus agglutin (DBA), and Lotus tetragonobulus 
agglutinin (LTA) for the proximal tubule, have shown that multiple segments of the 
nephron have the capacity to secrete fluid when stimulated by cAMP [11].  We have 
used this experimental model to explore the effects of ouabain in fluid secretion by 
the renal cystic epithelium.  Embryonic kidneys derived from Pkd1+/+, +/-, and -/- mice 
were dissected at E15.5 and cultured for 5 d as previously described [11].  Similar to 
cultures of ADPKD microcysts, treatment of the organs with ouabain alone did not 
have a noticeable effect on metanephric tubule dilation, regardless of the genotype 
(Figure 2).   
 In agreement with previous work by Magenheimer et al., treatment of kidneys 
derived from wild-type Pkd1+/+ mice with the cell-permeant cAMP derivative,  8-Br-
cAMP induced formation of cyst-like dilations in a series of renal tubules that 
continued to expand during the course of treatment (Figure 3A).  At the end of day 5, 
cysts comprised approximately 5% of the total kidney area, expressed as fractional 
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cyst area (Figure 3C).  Interestingly, when the wild-type metanephric cultures were 
treated with ouabain in the presence of 8-Br-cAMP, the cyst area doubled (Figure 3, 
B and C).  Likewise, metanephroi from heterozygous Pkd1+/- mice developed cystic 
disease with 8-Br-cAMP treatment (Figure 4A), and the concomitant addition of 
ouabain significantly exacerbated cyst growth (Figure 4B), as revealed by 
measurements of the fractional cyst area (Figure 3C).  Finally, metanephroi from 
homozygous, Pkd1-/- mice again showed a more severe response to both 8-Br-cAMP 
and ouabain than 8-Br-cAMP alone (Figure 5, A and B).  In the kidneys from these 
animals, ouabain exhibited the greatest effect, with a three-fold increase in the 
fractional cyst area (Figure 5C).  
 In conclusion, in the presence of 8-Br-cAMP, physiological levels of ouabain 
intensified cyst development in cultured metanephroi. Interestingly, the effect of 
ouabain on fractional cyst area was progressively higher in the comparison of 
metanephroi from Pkd1 wild-type, heterozygous and homozygous null mice (Figures 
3-5, panel B). The most dramatic effect was observed in the Pkd1-/- kidneys, 
suggesting that the severity of the disease correlates with an increase in the response 
of the tissue to ouabain. These results suggest that the effects of ouabain on cyst 
progression are not limited to ADPKD cells in culture, but also occur in the native 
environment of the renal tissue. 
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DISCUSSION 
 A hallmark in the development and enlargement of renal cysts in ADPKD is 
the secretion of salt and water through the kidney epithelium, which surpasses the 
reabsorbtive capacity of the cells and leads to accumulation of fluid into the cyst 
cavity [5, 11, 29].  Circulating agents, such as cAMP, have been shown to enhance 
fluid secretion and the progression of ADPKD.  We have previously shown that 
ouabain induces proliferation of ADPKD cells.  Here, we demonstrate that in addition 
to that effect, ouabain also acts as a co-factor in the stimulation of cyst growth and 
expansion by the ADPKD epithelium. Thus, the cAMP-dependent growth of 
microcysts of ADPKD cells cultured in a collagen matrix, as well as cysts from the 
well-characterized ADPKD mouse model Pkd1m1Bei, are significantly enhanced by 
ouabain.  This suggests that ouabain plays a dual role concomitantly enhancing cell 
growth and fluid secretion by the ADPKD epithelium. Importantly, this effect does 
not only take place in the isolated microcysts, but also in the environment of the 
whole renal metanephric organ, suggesting that it plays a role in cystogenesis in vivo.  
 The mechanism(s) of fluid accumulation in ADPKD cysts have been 
described as a disbalance between fluid reabsorption and secretion by the epithelium 
in favor of the latter [10, 30].  Reabsorption of Na+ and water in the renal epithelium 
is dependent primarily on the adequate function of the Na,K-ATPase at the 
basolateral domain of the cells.  The inward gradient of Na+ that the Na,K-ATPase 
generates is the major force that secondarily drives the transport of Na+ and other ions 
across the apical side of the renal epithelium [31].  Accordingly, inhibition of the 
  - 154 - 
Na,K-ATPase increases the levels of intracellular Na+ in the cells and affect the 
efficiency of the salt and water reabsorptive mechanisms across the renal tubule.  Our 
previous work has shown that ADPKD cells have an abnormally high sensitivity for 
ouabain and that approximately 20% of the total Na,K-ATPase is inhibited by 
physiological amounts of ouabain. This ouabain sensitive phenotype is restricted to 
ADPKD cells, since Na,K-ATPase from normal human kidney cells is not affected by 
physiological ouabain concentrations.  Therefore, it is possible that this partial 
inhibition of Na,K-ATPase activity is sufficient to impair fluid reabsorption through 
the epithelium, favoring the accumulation of salt and water at the luminal side of the 
cells, and thus, cyst enlargement.   
Our results show that treatment with ouabain alone does not result in a 
detectable effect on fluid secretion in the ADPKD microcysts or metanephric 
cultures.  This suggests that the role of ouabain in cysts development can not be 
attributed to just inhibition of the ion transport properties of the Na,K-ATPase.  
Studies in several cell types, and our own observations in ADPKD cells indicate that 
the Na,K-ATPase is involved in ouabain-induced signal transduction pathways that 
comprise a cascade of intracellular phosphorylating events, which start with the 
activation of the tyrosine kinase Src, the transactivation of the epidermal growth 
factor receptor (EGFR) and stimulation of the MAPK pathway [23, 32, 33].  Our 
results show that inhibition of MEK prevents the effects of ouabain in ADPKD 
microcyst formation, supporting the idea that the hormone switches on Na,K-ATPase 
signaling in the cells.  It is interesting to postulate that the ouabain-dependent 
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intracellular cascade of events could increase the activity of transporters involved in 
fluid secretion in ADPKD cells.  Ouabain has been shown to augment cAMP levels in 
renal cells [34], and cAMP has been implicated in the increased transport of Cl- via 
the cystic fibrosis transmembrane regulator (CFTR) transporter that causes cyst fluid 
accumulation.  It is plausible therefore, that ouabain could enhance the activity of 
CFTR by promoting cAMP production in the ADPKD cells.  The ability of ouabain 
to interact with the basolaterally located Na,K-ATPase to affect transporters distantly 
placed in the apical side of the cells has been recently reported.  Thus, in LLC-PK1 
cells, a well-characterized cell line from pig renal proximal tubule, basolateral 
treatment with ouabain down-regulated expression and activity of the 
sodium/hydrogen exchanger, NHE3 at the luminal side of the cells to reduce 
transepithelial Na+ transport [35].  Consistent with being mediated by Na,K-ATPase 
signaling, ouabain-dependent regulation of NHE3 in the LLC-PK1 cells required 
activation of Src and the integrity of plasma membrane caveolae [23].  
 The chloride-dependent secretion of fluid through the ADPKD epithelium 
requires that Cl- enters the cells via the basolateral membrane of the cells.  This is 
controlled by the function of  Na+,K+,2Cl- cotransporter, NKCC1 [10, 34].  The 
concerted action of NKCC1 and the CFTR to favor fluid movement to the luminal 
side of the tubular epithelium suggests they are concomitantly regulated.  
Experimental evidence for this mechanism comes from studies on the effects of 
adenylyl cyclase agonists, such as forskolin, or cAMP in ADPKD cells and in 
embryonic kidney cultures [9, 11, 24].  Both the CFTR and NKCC1 are regulated by 
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phosphorylation and dephosphorylation processes [36-39].  Among the many 
enzymes regulating the activity of CFTR, Src tyrosine kinase has been identified as 
one modifier of the channel's activity [40].  Therefore, by acting through the Na,K-
ATPase, ouabain-mediated activation of the MAPK pathway may lead to up-
regulation of both the CFTR and NKCC1 function, thereby increasing fluid secretion 
in ADPKD cells. 
 Importantly, the ouabain-mediated increase in cyst fractional area of ADPKD 
microcysts and metanephric organ cultures takes place at nanomolar concentrations of 
ouabain.  These ouabain amounts are similar to those normally present in blood, thus 
supporting the physiological importance of the effects of ouabain.  Because ADPKD 
are normally exposed to circulating ouabain, the hormone can act as an agent that will 
favor cyst development to worsen progression of the disease.  
 In conclusion, our results demonstrates a role for ouabain-Na,K-ATPase 
signaling in increasing cyst formation and expansion. This evidence, added to our 
previous observation indicating that ouabain stimulates cystic cell growth, further 
supports the importance of the hormone as a factor involved in the pathophysiology 
of and progression of ADPKD.  
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Figure 1.  ADPKD microcysts cultured in polymerized collagen treated with (A) 
Defined Media, (B) 5 μM forskolin, (C) 3 x 10-9 M ouabain, or (D) forskolin and 
ouabain.  Images are representative of 3 experiments performed in sextuplicate in 
cells obtained from three different ADPKD kidneys.  (E)  Values represent the 
average total surface area of cysts exceeding 100 μm in diameter.  Bars represent the 
means ± SE of two to three separate experiments in as many ADPKD kidneys, 
depending on the treatment regimen.  *P < 0.05 versus Defined Media, #P < 0.05 
versus forskolin. 
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Figure 2 
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Figure 2.  Metanephric cultures treated with 3 x 10-8 M ouabain for five days from 
(A) Pkd1+/+ , (B) Pkd1+/-, and (C) Pkd1-/- mice.  Media was replaced daily, and 
images were captured immediately afterwards.  Bar, 1mm.  Four experiments with 13 
pairs of kidneys did not reveal a significant effect of ouabain on tubule dilation in 
these mice. 
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Figure 3 
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Figure 3.  Metanephric cultures from Pkd1+/+ mice treated with (A) 100 μM 8-Br-
cAMP or (B) 100 μM 8-Br-cAMP and 3 x 10-8 M ouabain for five days.  Media was 
replaced daily, and images were captured immediately afterwards.  Bar, 1mm. (C) 
Fractional cyst area at the end of 5 days.  Bars represent the means ± SE of four 
experiments with 19 pairs of kidneys.  *P < 0.05 versus 8-Br-cAMP. 
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Figure 4 
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Figure 4.  Metanephric cultures from Pkd+/- mice treated with (A) 100 μM 8-Br-
cAMP or (B) 100 μM 8-Br-cAMP and 3 x 10-8 M ouabain for five days.  Media was 
replaced daily, and images were captured immediately afterwards.  Bar, 1mm.  (C) 
Fractional cyst area at the end of 5 days.  Bars represent the means ± SE of three 
experiments with 12 pairs of kidneys.  *P < 0.05 versus 8-Br-cAMP. 
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Figure 5 
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Figure 5.  Metanephric cultures from Pkd-/- mice treated with (A) 100 μM 8-Br-cAMP 
or (B) 100 μM 8-Br-cAMP and 3 x 10-8 M ouabain for five days.  Media was replaced 
daily, and images were captured immediately afterwards.  Bar, 1mm. (C) Fractional 
cyst area at the end of 5 days.  Bars represent the means ± SE of three experiments 
with 4 pairs of kidneys.  *P < 0.05 versus 8-Br-cAMP. 
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CHAPTER 6 
 
ASSOCIATION WITH POLYCYSTIN-1 AFFECTS Na,K-ATPase FUNCTION 
 
ABSTRACT 
 
 Experimental evidence in the last few years has shown that the Na,K-ATPase 
interacts with a variety of soluble and membrane-bound proteins in the cell.  
Interestingly, the Na,K-ATPase α1 polypeptide has been shown to associate with the 
C-terminal tail of polycystin-1.  Polycystins-1 and -2 (PC-1 and PC-2) are plasma 
membrane proteins that are altered in their expression patterns in autosomal 
polycystic kidney disease (ADPKD).  To determine whether interaction with 
polycystins affect the function of the Na,K-ATPase, we expressed the proteins in Sf-9 
insect cells using baculoviruses.  When the eleven transmembrane domains and C-tail 
of PC-1 or the full length PC-2 were expressed with the rat Na,K-ATPase α1 isoform, 
high levels of all polypeptides were detected at the plasma membrane and cytoplasm 
of the cells. Immunoprecipitation analysis indicated physical interaction between PC-
1 and the Na,K-ATPase, but a negative association of the enzyme with PC-2.  
Analysis of the Na,K-ATPase kinetic properties showed no important changes in the 
apparent affinities of the enzyme to Na+ and K+, both in the presence of PC-1 and PC-
2.  Dose-response curves for the inhibition of Na,K-ATPase activity by ouabain 
varied depending on the type of polycystin present.  While PC-2 was not able to 
modify the normal resistance of the Na,K-ATPase α1 isoform, PC-1 induced a shift in 
sensitivity to ouabain, with a change in Ki from ~10-5 M to ~10-8 M.  Co-expression 
of PC-1 with the Na,K-ATPase in Sf-9 cells also increased the ability of the enzyme 
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to transduce the signaling effects of ouabain in the cells.  Thus, in the presence of PC-
1, ouabain-dependent phosphorylation of ERK was observed.  The modulation of 
Na,K-ATPase response to ouabain by PC-1 may be important in the regulation of 
fluid transport and cell growth in the renal epithelium, and could contribute to the 
formation and maintenance of cysts in PKD.  
 
  - 175 - 
INTRODUCTION 
 Autosomal dominant polycystic kidney disease (ADPKD) is the most 
common monogenic disease with an incidence of 1:1000, and is characterized by 
multiple fluid-filled cysts found in the kidneys, liver, pancreas and other organs.  In 
the kidneys, the many cysts distort and damage the organ, leading to end-stage renal 
failure in appoximately 50% of ADPKD patients  [1, 2].   
 Approximately 85% of all cases of ADPKD result from a mutation in the 
Pkd1 gene, encoding for a 450-460 kDa transmembrane protein called polycystin-1 
(PC-1).  This protein is predicted to span the membrane 11 times, with a large 
extracellular domain containing multiple motifs suggesting several roles, including 
cell-cell and cell-matrix interactions.  The substantially smaller intracellular carboxyl-
terminal region contains a G protein-binding motif and coiled-coil domain [1, 3].  The 
remaining cases of ADPKD are due to defects in the Pkd2 gene, encoding for a ~110 
kDa protein called polycystin-2 (PC-2).  This protein spans the membrane six times, 
and has been shown to be a cation channel with permeability for Ca2+.  PC-1 and PC-
2 physically interact via their coiled-coil domains in their cytoplasmic C-terminal 
tails, but can also function independently in various subcellular compartments.  While 
mutations in either gene results in cystic disease, alterations in Pkd1 lead to a more 
severe phenotype [1, 2, 4].  Interestingly, mutations in either gene may not 
necessarily result in alterations in expression levels of the protein.  In primary 
cultures of epithelial cells derived from normal and cystic kidneys, there were similar 
levels of PC-1 expression with no obvious changes in the size of the protein.  
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However, there were differences in localization of the protein.  For example, lower 
levels of PC-1 were found at the plasma membrane of ADPKD cells than in normal 
cells.  Thus, it has been suggested that alterations in PC-1 localization are coincident 
with the disease status [3].  Thus, a key issue in understanding ADPKD is to elucidate 
how alterations in the functions of the polycystins can lead to cystogenesis. 
 The C-tail of polycystin-1 has been found to interact with the α subunit of the 
Na,K-ATPase in yeast two-hybrid screens, in vivo in Madin-Darby canine kidney 
(MDCK) cells and in kidneys of transgenic mice overexpressing PC-1 [5, 6].  
Operating at the basolateral membrane in normal kidneys, the Na,K-ATPase 
establishes an inward gradient of Na+ that secondarily drives the transport of other 
ions, glucose, amino acids and water across the renal epithelium [7].  Because of the 
crucial role of the Na,K-ATPase in Na+ and water absorption, alterations in its 
function may adversely affect renal function.  In ADPKD, there is an alteration in the 
renal epithelium that switches it from being absorptive to secretory.  Thus, alterations 
in the activity or regulation of the Na,K-ATPase may contribute to the pathogenesis 
of ADPKD. 
 Our studies of the kinetic properties of the Na,K-ATPase from epithelial cells 
of normal and ADPKD kidneys revealed that a population of the enzyme has a higher 
affinity for its inhibitor, ouabain [8].  In ADPKD, the altered ouabain sensitivity is 
not due to misexpression of isozymes of the Na,K-ATPase, since like normal cells, 
expression of only  α1β1 was found in ADPKD cells .  It is possible that the 
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functional changes of the Na,K-ATPase depend on interaction of the enzyme with 
PC-1 or PC-2 [9].   
 In addition to regulating the transport activity of the enzyme, the altered 
sensitivity of the Na,K-ATPase to ouabain may have other important consequences.  
The Na,K-ATPase is the receptor for cardiotonic steroids, such as ouabain [7].    
Ouabain is a well characterized hormone that is synthesized in the adrenal glands of 
several mammal, including man [10].  Ouabain binding to the α subunit of the Na,K-
ATPase has been shown to initiate a cascade of intracellular phosphorylating events 
that lead to transactivation of the epidermal growth factor receptor (EGFR) and 
subsequent phosphorylation and activation of numerous proteins, including the 
mitogen activated MEK and MAP kinases [11].  These phosphorylating events result 
in increased expression of genes that are associated with cell growth and proliferation 
[11-13]. 
 In this work, we studied the effect of the association between PC-1 and the 
Na,K-ATPase on the ouabain sensitivity, as well as the signaling ability of the 
enzyme.  For this, we used the baculovirus expression system to express the Na,K-
ATPase and polycystins in Sf-9 insect cells.  These cells are uniquely suited for 
studying various aspects of Na,K-ATPase function, as they contain negligible 
endogenous levels of the enzyme [14].  Furthermore, they can produce abundant 
amounts of the transporter that are functional and retain their intrinsic ouabain 
binding capabilities [14].  Recent work has shown that   the signaling role of the 
Na,K-ATPase is also retained in Sf-9 cells.  Using this system, we explored the effect 
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of PC-1 and PC-2 on the ouabain affinity and ouabain-dependent signaling capacity 
of the Na,K-ATPase.  Our results show an interaction between the Na,K-ATPase and 
a construct for PC-1 containing the 11 transmembrane domains and C-terminal tail.  
This interaction affects the affinity of the Na,K-ATPase for ouabain, rendering it 
more sensitive by several orders of magnitude; the affinity of the enzyme for the 
cations Na+ and K+ remain unchanged.  In contrast, the Na,K-ATPase does not 
interact with an HA-tagged, full-length PC-2 and thus, its properties are not altered.  
This suggests that binding of PC-1 to the Na,K-ATPase is a mechanism of regulating 
the activity of the enzyme. 
 We found that the influence of PC-1 on the Na,K-ATPase not only enhanced 
the enzyme's affinity for ouabain, but stimulated its response to activate ERK 
phosphorylation with low levels of the hormone.  The abnormal sensitivity of the 
Na,K-ATPase to ouabain in ADPKD cells may cause an alteration in the ouabain-
Na,K-ATPase mediated signaling cascade, contributing to cystogenesis and 
maintenance.   
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METHODS 
DNA and viral constructions 
 The cDNAs used in this study included: a) the α1 and β1 subunits of the rat 
Na,K-ATPase, b) sIg11TM, a PC-1 construct (generously provided by Dr. R. Maser, 
KUMC) that included the 11 transmembrane domains and C-terminal tail of PC1 
fused to a CD5 signal sequence for membrane insertion and the CH2-CH3 domain of 
human IgG for protein recognition, c) sIg11STOP, used as a control for sIg11TM, 
contained a stop codon after the first transmembrane domain, d) HA-PC2, a full-
length PC-2 tagged with HA in the extracellular region of the polypeptide, between 
transmembrane segments 1 and 2 (generously provided by Dr. L. Tsiokas, Harvard 
Medical School), and e) HA-PC2STOP, used as a control for PC-2, contained HA and 
the first two transmembrane domains of PC-2.  All constructs were subcloned into 
pBlueBac 4.5 baculovirus vector and recombinant baculoviruses were prepared and 
selected following standard procedures [15].  The resulting polypeptides of each 
construct are represented in a schematic diagram in Figure1. 
 
Cell and viral infections 
 Sf-9 cells were grown in TNM:FH medium supplemented with 10% fetal 
bovine serum, 100 units/ml penicillin, 100 mg/ml streptomycin and 0.25 mg/ml 
fungizone. Viral infections were performed for 72 h. Cells were then scraped from the 
plates, centrifuged at 1,500 x g for 10 min and resuspended in 10 mM imidazole 
hydrochloride (pH 7.5), 1 mM EGTA. For determination of enzymatic activity, the 
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intact cells were used after permeabilization with the ionophore alamethicin (0.1 
mg/mg of protein) for 10 min at 25 °C.  
 
Immunoblot analysis 
 Proteins were analyzed by SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) and immunoblotting. After separation by SDS-PAGE, proteins were 
transferred to nitrocellulose and immunoblotted.  The Na,K-ATPase α1 subunit was 
detected using the polyclonal anti-α1 synthetic peptide antiserum or anti-α1 C464/6B 
monoclonal antibody (provided by Dr. M. Caplan, Yale Univ.), sIg11TM and 
sIg11STOP were identified with an antibody against the human IgG. For HA-PC2 
and HA-PC2STOP an antibody against HA was used.  Phosphorylated ERK and total 
ERK levels were detected using antibodies from Santa Cruz Biotechnology (Santa 
Cruz, CA).  Horseradish peroxidase-labeled antisera and chemiluminescence was 
used for detection.  Quantitation of ERK activation was done by measuring band 
intensities of scanned images using the Gel-Pro software (Media Cybernetics, Silver 
Spring, MD).  Levels of P-ERK and total ERK were expressed as density units 
relative to the untreated controls, and presented as P-ERK to total ERK ratios. 
 
Immunoprecipitation 
 Sf-9 cells infected for 72h were lysed at 4°C with lysis buffer containing 
0.01% SDS, 1% Triton X-100, 150mM sodium chloride and 25mM Hepes, pH 7.4.  
After removal of insoluble material by centrifugation (15,000 x g, 3 min), the cleared 
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lysates were subjected to immunoprecipitation. For PC1, the Na,K-ATPase was 
immunoprecipitated using 60 µL of the anti-α1, C464/6B monoclonal antibody and 
50 µL of goat anti-mouse IgG Dynabeads (Dynal Biotech, Inc., Lake Success, NY).  
For HA-PC2, 4 µg of a monoclonal antibody to the HA epitope (Santa Cruz 
Biotechnology, Santa Cruz, CA) with 40 µL of Goat anti-mouse IgG Dynabeads were 
used.  In all cases, the lysates were incubated on a rotator overnight at 4°C, washed 3 
times with lysis buffer, and the precipitated proteins were analyzed by SDS-PAGE 
(7.5% gel) and immunoblotted as described above. 
 
Immunocytochemistry and Confocal Microscopy 
 Sf-9 cells were plated on 18mm glass coverslips, infected for 72h and 
processed for immunocytochemistry.  The Na,K-ATPase was detected either with 
C464/6B or anti-α1 synthetic peptide.  sIg11TM and sIg11STOP were detected with 
an antibody to the human IgG conjugated to flourescein isothiocyanate (FITC). HA-
PC2 and HA-PC2STOP were detected with the anti-HA monoclonal antibody. 
Rhodamine-conjugated Goat anti-mouse IgG or FITC-conjugated Goat anti-rabbit 
IgG (Molecular Probes, Eugene, OR) were used as secondary antibodies.  Samples 
were analysed using a Zeiss LSM 510 confocal microscope. 
 
Na,K-ATPase assays 
 Maximal Na,K-ATPase activity was determined at 37˚C for 30 min by 
measuring the initial rate of release of  γ32Pi from  γ[32P]-ATP in a final volume of 
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0.25 mL of medium containing 120 mM NaCl, 30 mM KCl, 3 mM MgCl2, 0.2 mM 
EGTA, 2 mM sodium azide, 30 mM Tris-HCl (pH 7.4) ± 1 mM ouabain, and 3 mM 
ATP with 0.2 µCi γ[32P]ATP.  For the analysis of activation by Na+ and K+, 
incubation media was the same as above except that for Na+ dependency, Na+ 
concentration was varied from 0 to 125 mM.  For K+ stimulation, K+ was varied from 
0 to 30 mM.  Choline chloride was added to maintain the final concentration of Na+ 
and K+ plus choline at 180 mM. Ouabain dose-response was determined under 
saturating concentrations of all other cations at the indicated ouabain concentrations. 
 
Ouabain treatment and processing of cells for ERK analysis 
 Following infection, cells were incubated for 48 h at 27˚C when the complete 
culture media was changed to serum-free media.  After an additional 24 h incubation 
period, cells were treated with or without 3 x 10-8 M ouabain for 15 minutes.  
Experimental treatment was stopped by removing the media and washing the cells 
with ice-cold PBS.  Cells were then lysed in RIPA buffer containing 1% NP-40, 
0.25% sodium deoxycholate, 1 mM sodium orthovanadate, 1 mM sodium fluoride, 
150 mM NaCl, 1 mM EDTA, 50 mM Tris and protease inhibitor cocktail (Sigma, St. 
Louis, MO).  30 μg of the cleared lysates were analyzed by 10% SDS-PAGE and 
immunoblotted as described [16].   
 
Data analysis 
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 Curve fitting of the experimental points was carried out using a Marquardt 
least-squares non linear regression computing program (Sigma Plot,  Jandel 
Scientific, San Rafael, CA).  Na+ and K+ activation curves were fitted according to a 
cooperative model for ligand binding:   
  v = (Vm [S]n)/(K) + [S]n) 
Where S is the concentration of the activating cation (Na+ or K+) and n is the Hill 
coefficient.  The apparent affinity, K0.5 =  K1/n. 
Dose-response relations for the ouabain inhibition of Na,K-ATPase activity were 
fitted by the equation:  v = 100 (1/(1 + [I]/Ki)) 
Where v is the Na,K-ATPase activity corresponding to a certain concentration of the 
inhibitor ouabain [I], expressed as a fraction of activity in the absence of ouabain, and 
Ki is the concentration of ouabain that gives the half-maximal inhibition.   
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RESULTS 
The Na,K-ATPase associates with polycystin-1 
 To study the physical interaction and functional consequences of an 
association between the Na,K-ATPase and PC-1, we expressed the respective 
polypeptides in insect cells using baculoviruses (Figures 1A and 1B).  
Immunolocalization studies revealed high levels of each polypeptide, primarily at the 
plasma membrane (Figure 2).  Immunoblot analyses of whole lysates and co-
immunoprecipitated complexes revealed that the presence of either sIg11TM or its 
control did not affect Na,K-ATPase expression (Figure 3A).  Likewise, sIg11TM and 
its control were detected at high levels when co-expressed with Na,K-ATPase (Figure 
3B).  Thus, the baculovirus system is well suited to examine the proteins in this study.   
 Interaction of sIg11TM or its control with Na,K-ATPase was determined by 
co-immunoprecipitation with an antibody against the α1 subunit of the Na,K-ATPase.  
As shown in Figure 3C, the immunocomplex captured by the anti-α1 antibody 
indicated only sIg11TM, and not its control, co-immunoprecipitated with the Na,K-
ATPase.  This suggests that the large extracellular domain of PC-1 is not required for 
its association with the Na,K-ATPase.   
 
 Association of the Na,K-ATPase with polycystin-1 affects its enzymatic activity 
    As a first approach to understand the consequences of the interaction of the 
Na,K-ATPase with sIg11TM, we determined the kinetic properties of the enzyme in 
co-infected Sf-9 cells.  As shown in Figure 4, the activation curves by Na+ and K+ 
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indicated no significant differences in the presence or absence of sIg11TM.  In 
contrast, dose-response curves of Na,K-ATPase activity showed that when co-
expressed with sIg11TM, the Na,K-ATPase displays an affinity for ouabain that is 
higher than that of the α1β1 complex alone.  The presence of sIg11TM produced a 
shift in the affinity of the enzyme for ouabain by three orders of magnitude, with a 
change in Ki from approximately 3 x 10-5 M to 3 x 10-8 M (Table 1).  These results 
indicate that PC-1 is able to affect the sensitivity of the Na,K-ATPase α1β1 isozyme 
to ouabain. 
 
The Na,K-ATPase does not interact with polycystin-2, and its enzymatic activity is 
unchanged 
 In addition to PC-1, we explored the interaction between the Na,K-ATPase 
and PC-2.  To do so, two constructs were prepared: one contained the full length PC-
2 tagged with HA in the extracellular region of the polypeptide, between 
transmembrane segments one and two (HA-PC2).  Its control, HA-PC2STOP, 
contained only the first two transmembrane domains with the HA tag; the C-terminal 
tail is absent (Figure 1C).  These constructs were used to produce baculoviruses for 
expression in Sf-9 cells in conjunction with the Na,K-ATPase.  We repeated the same 
analyses as done with sIg11TM to examine if PC-2 affected function of the enzyme.   
 Similar to the expression of sIg11TM, we detected high levels of PC-2 and its 
control in Sf-9 cells co-expressing the α1β1 heterodimer of the Na,K-ATPase.  
Immunofluorescence imaging of the polypeptides, shown in Figure 5, found PC-2 and 
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its control to be found both at the plasma membrane and in the cytoplasm of Sf-9 
cells, while the Na,K-ATPase was delivered to the plasma membrane.  Western blot 
analyses of Sf-9 cells co-expressing the Na,K-ATPase with PC-2 or its control also 
revealed high levels of each polypeptide (Figure 6A and 6B).  Immunoprecipitation 
using an anti-HA antibody to pull down PC-2 and anti-Na,K-ATPase α1 for 
identification of the transporter in immunoblots showed no association of the Na,K-
ATPase with PC-2 (Figure 6C).  Not surprisingly, the presence of PC-2 or its control 
in Sf-9 cells co-expressing the α1β1 isozyme of the Na,K-ATPase did not affect its 
enzymatic properties.  As shown in Figure 7 and summarized in Table 2, neither PC-2 
nor its control altered the affinity of the Na,K-ATPase for its ligands, Na+ and K+, or 
for the inhibitor ouabain.   
 These studies confirmed an interaction of the Na,K-ATPase with PC-1, but 
not PC-2, and this interaction only alters its sensitivity to the hormone ouabain and 
not for the cations. 
   
Ouabain signaling via the Na,K-ATPase is enhanced by PC-1 
 Previous works have revealed that ouabain binding to the Na,K-ATPase is not 
just to restrict its catalytic and transport properties, but it also serves as a signal for 
Na,K-ATPase-mediated cellular effects.  We have shown that physiological levels of 
ouabain leads to ERK activation in renal epithelial cells from patients with autosomal 
dominant polycystic kidney disease (ADPKD), while there is not a significant effect 
in cells from normal kidneys [16].  Furthermore, there is a population of the enzyme 
  - 187 - 
that is more sensitive to ouabain, although the isozyme composition did not differ 
between the normal and cystic tissue.  This suggests that the heightened sensitivity of 
the Na,K-ATPase to ouabain may be attributed to interaction with PC-1.   
 To determine the role of PC-1 on altering the signaling capacity of the Na,K-
ATPase, we used the baculovirus expression system, and determined ouabain/Na,K-
ATPase signaling by ERK activation.  We found that when the Na,K-ATPase was co-
expressed with sIg11TM in Sf-9 cells, treatment with 3 x 10-8 M ouabain stimulated 
phosphorylation of ERK (Figure 8).  In contrast, cells expressing sIg11STOP or PC-2 
with the Na,K-ATPase did not lead to ERK activation after treatment with ouabain.  
Therefore, the heightened sensitivity of the Na,K-ATPase to ouabain due to its 
interaction with PC-1 may result in enhanced ouabain/Na,K-ATPase signaling in 
ADPKD. 
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DISCUSSION 
 The affinity of the Na,K-ATPase to ouabain is a key factor in regulating the 
"pumping" activity of the enzyme, as well as the cellular response to the hormone.  
Protein-protein interaction has been shown to affect some enzymatic properties of the 
Na,K-ATPase [17].  In this work using the heterologous baculovirus expression 
system, we were able to study the interaction of the Na,K-ATPase with the 
polycystins.  We confirmed an interaction of the Na,K-ATPase with PC-1, most 
likely via the C-tail of PC-1, in agreement with previous reports [5, 6].  In addition, 
we determined the functional relevance of that association in an environment 
essentially free of endogenous Na,K-ATPase [14].  Interestingly, although PC-1 and 
PC-2 have been demonstrated both in vitro and in vivo to interact via their C-terminal 
tails [2, 18], PC-2 was not found to interact with the Na,K-ATPase.  One explanation 
for this curious finding may be that the Na,K-ATPase only interacts with PC-1 in the 
disease state when PC-1 and PC-2 are not functioning normally. 
 Mutations in the genes encoding for polycystin-1 and -2 do not necessarily 
result in a loss of expression of these proteins.  Rather, it may result in functionally 
defective or null proteins.  It has been suggested that a disruption in the 
stoichiometric balance of the two polycystins can result in cyst development [3, 19, 
20].  It is possible that when this balance is disrupted, PC-1 cannot interact with PC-2 
as it normally would, and instead interacts with the Na,K-ATPase to affect its 
function.  Most notably, it alters the enzyme's affinity for the steroid hormone 
ouabain by three orders of magnitude, similar to the Ki of the sensitive component 
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found in cystic kidneys and cells [16], and consistent with levels that are found in 
circulation.  The consequences of this alteration lie in the role of the Na,K-ATPase as 
a signal transducer for the hormone [11, 21]. 
 Cyst formation and enlargement have been found to be associated with 
activation of tyrosine kinase-mediated signaling, as well as cAMP-mediated signaling 
[2, 22-24].  A central pathway activated in ADPKD leading to cell growth involves 
the extracellular regulated kinase (MAPK/ERK) pathway, with an abnormal 
abundance and activation of B-Raf by cAMP-mediated PKA activation [25-27].  
Because Sf-9 cells express ERK that can be modified by phosphorylation [28], we 
were able to study the signaling capacity of the Na,K-ATPase in the presence of PC-1 
or PC-2.  Our work revealed that PC-1, but not PC-2, enhanced the ouabain/Na,K-
ATPase signaling. 
 The interaction of the Na,K-ATPase with PC-1 and subsequent alteration in 
the enzyme's affinity for ouabain may have important consequences in the 
pathophysiology of ADPKD.  By inhibiting the "pumping" activities of the Na,K-
ATPase, it may dissipate the Na+ gradient, thereby limiting optimal water 
reabsorption to allow greater fluid secretion into the cyst cavity, allowing the cysts to 
expand.  Concomitantly, the altered sensitivity of the Na,K-ATPase to ouabain may 
render it more susceptible to the proliferative effects of the hormone.  These studies 
revealing that PC-1 altered the sensitivity of the Na,K-ATPase to ouabain, and 
enhanced ouabain/Na,K-ATPase signaling may be the mechanism by which the 
hormone can adversely affect the progression of ADPKD. 
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Figure 1.  Schematic models of the various polypeptides used in this study.  (A) The α 
subunit of the Na,K-ATPase is represented, and its interaction with polycystin-1 is 
believed to occur within the N-terminal tail, the cytosolic loop between 
transmembrane domains 2 and 3, and/or the large intracellular loop between 
transmembrane segments 4 and 5 [5, 6].  (B)  The construct for polycystin-1, 
sIg11TM, and its control, sIg11STOP.  The CD5 sequence directs trafficking of the 
protein to the plasma membrane, while the IgG domain is for protein recognition.  All 
11 transmembrane domains and the full C-terminal tail comprise sIg11TM, while 
sIg11STOP only expresses the signal sequence, IgG and first transmembrane 
domains.  (C)  The construct for PC2, HA-PC2, contains the full-length protein with 
an HA tag between the first two transmembrane domains.  In contrast, its control, 
HA-PC2STOP, does not extend beyond the first two transmembrane sequences.   
  - 195 - 
Figure 2 
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Figure 2.  Immunolocalization of Na,K-ATPase and sIg11TM or sIg11STOP in Sf-9 
cells. (A) Expression of the Na,K-ATPase α1 subunit and sIg11TM. (B) Cells 
coinfected with Na,K-ATPase α1 and sIg11STOP. The α1 subunit was detected with 
the C464/6B monoclonal antibody and a rhodamine conjugated secondary antibody. 
sIg11TM and sIg11STOP were detected with an antibody against the human IgG 
domain conjugated to FITC. All polypeptides were expressed at high levels and 
colocalized primarily to the plasma membrane of the cells.  Bar, 10 μm. 
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Figure 3 
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Figure 3.  Immunoblot and immunoprecipitation analysis.  Sf-9 cells coinfected with 
baculoviruses driving expression of Na,K-ATPase α1β1 and sIg11TM or sIg11STOP 
were analyzed for expression of (A) the α1 and (B) the sIg11TM or sIg11STOP 
polypeptides.  (C) Immunoprecipitation of the Na,K-ATPase α1 subunit and sIg11TM 
and sIg11STOP constructs. C464/6B antibody was used for immunoprecipitation and 
an antiserum that recognizes human IgG was used for the immunoblot. The Na,K-
ATPase associates with sIg11TM, but not sIg11STOP. 
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Figure 4 
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Figure 4.  Na,K-ATPase kinetic properties in the absence and presence of PC-1 
constructs.  (A) Dose-response curves for the ouabain inhibition of Na,K-ATPase 
α1β1 activity + sIg11TM and sIg11STOP. (B) Activation of α1β1 by Na+ + sIg11TM. 
(C) Activation of α1β1 by K+ + sIg11TM.  While  sIg11TM did not affect the 
apparent affinities of the Na,K-ATPase to Na+ and K+, it changed the affinity for 
ouabain, making the enzyme more sensitive to the compound. 
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Figure 5 
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Figure 5.  Immunolocalization of Na,K-ATPase and HA-PC2 or HA-PC2STOP in Sf-
9 cells. (A) Expression of the Na,K-ATPase α1 subunit and HA-PC2. (B) Cells 
coinfected with Na,K-ATPase α1 and HA-PC2STOP. The α1 subunit was detected 
using the anti-α1 synthetic peptide antiserum and an anti-rabbit conjugated with 
FITC. HA-PC2 and HA-PC2STOP were detected by a monoclonal antibody to the 
HA epitope and a secondary antiserum conjugated to rhodamine. All polypeptides 
were expressed at high levels.  While the α1 polypeptide localized primarily to the 
membrane, HA-PC2 and HA-PC2STOP were found both at the plasma membrane 
and cytoplasm.  Bar, 10 μm. 
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Figure 6 
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Figure 6.  Immunoblot and Immunoprecipitation analysis. Sf-9 cells coinfected with 
rat Na,K-ATPase α1β1 and HA-PC2 or HA-PC2STOP were analyzed for expression 
of (A) the α1 and (B) HA-PC2 or HA-PC2STOP polypeptides. (C) 
Immunoprecipitation of PC-2 constructs and the Na,K-ATPase. An antiserum against 
HA was used for immunoprecipitation, and anti-α1 synthetic peptide was used for the 
immunoblot. Neither HA-PC2, nor HA-PC2STOP associate with the Na,K-ATPase. 
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Figure 7 
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Figure 7.  Na,K-ATPase kinetic properties in the absence and presence of PC2 
constructs.  (A) Dose-response curves for the ouabain inhibition of Na,K-ATPase 
α1β1 activity + HA-PC2 and its control, HA-PC2STOP. (B) Activation of α1β1 by 
Na+ + HA-PC2. (C) Activation of α1β1 by K+ + HA-PC2.  PC2 does not modify the 
kinetic properties of Na,K-ATPase α1β1 to Na+, K+ or ouabain. 
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Figure 8.  Ouabain-Na,K-ATPase mediated ERK phosphorylation in the presence and 
absence of sIg11TM in insect cells.  Sf-9 cells expressing rat Na,K-ATPase α1β1 
alone or with sIg11TM or sIG11STOP were treated with culture media alone (solid 
bar) or with 3 x 10-8 M ouabain (dashed bars) for 15 min.  Phospho-ERK/total ERK 
ratios were normalized against the untreated control cells expressing Na,K-ATPase 
α1β1 alone.  A representative blot is shown, while bars are means ± SE of 3 
independent experiments.  *P<0.001 vs untreated control. 
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OVERALL CONCLUSIONS 
Cyst formation and development in autosomal dominant polycystic kidney 
disease (ADPKD) is characterized by increases in both cell proliferation and 
apoptosis, as well as in alterations in the renal epithelium such that fluid is secreted 
into the cyst cavity instead of being reabsorbed into the bloodstream.  Understanding 
the factors that influence these parameters in ADPKD cells is essential in 
comprehending the mechanism(s) involved in cystogenesis, as well as for the future 
development of approaches that can be used to control the progression of the disease.  
Because of its central role in the vectorial movement of salt and water, the ion 
transport properties of the Na,K-ATPase have been the focus of investigation to 
understand the pathophysiology of ADPKD.  Interestingly, in addition to its activity 
as an ion transporter, the Na,K-ATPase also functions as the receptor and signal 
transducer for ouabain. Ouabain is a well characterized hormone known to trigger 
signaling events that induce changes in metabolism, motility and growth in several 
cell types.  At present, no information is available regarding the role of ouabain-
Na,K-ATPase signaling in ADPKD.  We have studied this issue in this work. 
Surprisingly, we have found that the Na,K-ATPase of human ADPKD cells exhibit an 
abnormal increase in the affinity for ouabain.  Moreover, we have also found that 
ouabain, in amounts similar to those circulating in blood, stimulated ADPKD cell 
growth by approximately 40 %.  In contrast, the hormone does not significantly affect 
proliferation of normal human kidney epithelial cells, which coincidentally have a 
lower affinity for the hormone. 
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Ouabain-induced proliferation depended on activation of EGFR, Src, B-Raf, 
MEK and ERK1/2. Upon activation, phosphorylated ERK1/2 translocates to the 
nucleus where it likely activates transcription of genes involved in cell growth and 
proliferation.  Activation of this cascade of intracellular events required integrity of 
cellular caveolae, where the Na,K-ATPase has been shown to form a signaling 
complex, described in other cell types, as the signalosome.   Our results agree with 
the existence of the Na,K-ATPase signalosome in ADPKD cells, and it involves 
pathways that are shared with those of other cell types.  Importantly, our results are 
one of the first to establish ouabain signaling in diseased cells.  More importantly, 
ADPKD cells have a higher affinity for ouabain, and are thus more susceptible to 
signaling ouabain effects into the cells.  The cascade of intracellular signaling events 
we identified to be induced by ouabain have been shown to be of critical importance 
in mediating the progression of PKD.  For example, targeting these signaling 
molecules by pharmacological intervention in rodent models of PKD have been 
shown to attenuate the disease, confirming the importance of this signaling pathway 
in ADPKD pathophysiology.  Our results have therefore uncovered a new mechanism 
capable of influencing cyst growth.  Compounds that can compete for ouabain 
binding to the Na,K-ATPase and block its signaling have been developed and are 
under clinical phase trials.  This includes, for example, the drug Rostafuroxin (PST 
2238) [1, 2]. Also Digibind, a Fab fragment of antisera directed against digoxin, has 
been shown to reverse the inhibitory effect of ouabain on the activity of the Na,K-
ATPase, most likely by immunoneutralization [3].  It is expected that future use of 
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these compounds would be of benefit in preventing endogenous ouabain from binding 
to the Na,K-ATPase in cystic tissue.  This could block ouabain-stimulated growth in 
ADPKD cells, to decrease the epithelial proliferation required for cyst expansion. 
In addition to its mitogenic effect, we found that physiological levels of ouabain 
also promote apoptotic death of ADPKD cells, as determined by DNA fragmentation 
and TUNEL assay.  Increased apoptosis has been reported in ADPKD, and inhibition 
of this process in a rodent model of ADPKD has been shown to slow progression of 
the disease.  Ouabain-dependent increase in apoptosis does not parallel the increase 
the hormone causes in cell proliferation.  This shows that ouabain induces a 
disbalance in cell proliferation and removal that favors growth of the ADPKD 
epithelium.  This dual effect of ouabain on cell proliferation and apoptosis further 
supports its role in exacerbation of the disease.  The disbalance in cell renewal has 
been identified as an important characteristic of the ADPKD epithelium.  Our results 
have identified ouabain as one of the mechanism(s) leading to the abnormal 
regulation of cell growth in ADPKD.  In addition, we provide evidence for the 
pathways through which ouabain promotes cell apoptosis.  Upon ouabain exposure, 
caspase-3 is activated in the cells. Ouabain also stimulated the release of 
mitochondrial cytochrome c into the cell cytoplasm.  This suggested that ouabain-
mediated apoptosis takes place via the intrinsic pathway of apoptotic cell death. 
Our results show that ouabain also affects cyst development.  Thus, the 
hormone increased the number and size of microcysts formed by ADPKD cells in 
three dimensional collagen cultures.  Also, ouabain enhanced the fractional area of 
 214 
cysts developed by metanephric organ cultures from Pkd1m1Bei mice, an animal model 
of ADPKD. This suggests that ouabain may not only act by promoting cell 
proliferation, but also by activating the mechanisms involved in fluid secretion by the 
ADPKD epithelium.  Although additional experiments will be conducted in the future 
to confirm the role of ouabain in regulating fluid secretion, it is interesting to propose 
that ouabain may be acting in two ways to enhance fluid movement into the cyst 
cavity.  One involves the ion transport activity of the Na,K-ATPase, and comprises a 
partial inhibition of the enzyme by ouabain, which will reduce the reabsorbing 
capacity of the epithelium.  The second involves the signaling ability of the Na,K-
ATPase, which by activating intracellular signaling events that may increase cAMP 
levels, may induce post-translational modifications to proteins involved in fluid 
secretion, such as the NKCC1 or CFTR.  Both of these transporters have been 
identified as the major routes for salt and water secretion in ADPKD that is under the 
influence of the MAPK pathway.  The similarity in pathways activated by ouabain 
with those reported to cause activation of NKCC1 and CFTR supports these 
hypothesis.  
An intriguing observation from our experiments is the alteration in the ouabain 
affinity phenotype of the Na,K-ATPase of ADPKD cells.  We found that 
approximately 20% of the Na,K-ATPase of ADPKD cells is able to bind ouabain with 
an inhibition constant in the nanomolar range.  We have demonstrated that this 
change in ouabain affinity does not depend on mis-expression of different isoforms of 
the Na,K-ATPase, as the cystic cells present the α1β1 isozyme normally present in 
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kidney cells.  Interestingly we show that association of the Na,K-ATPase with PC-1 
causes the phenotypic switch on ouabain affinity of the enzyme.  Interaction with PC-
1 had previously been reported, using overexpression of both polypeptides in CHO 
cells and in animal models of ADPKD.  Our work is the first demonstration that 
Na,K-ATPase interaction with PC-1 is functionally relevant and modulates the 
reactivity of the enzyme to ouabain.  Our results in insect cells using baculovirus-
directed expression show that the increased reactivity to ouabain also causes 
increased ability of the Na,K-ATPase to signal ouabain effects in the cells. In 
ADPKD, expression of mutated and deleted forms of PC-1 has been reported to act as 
dominant negative forms of the polypeptide causing the disease.  From the 
experimental evidence we gathered, we propose a model in which the affinity of the 
Na,K-ATPase for ouabain is increased by enhanced association with PC-1.  This will 
make the ADPKD cells more sensitive to circulating levels of ouabain.  Na,K-ATPase 
signaling in these cells will then be abnormally activated and the effects of ouabain in 
cell growth and fluid secretion enhanced.  This will exacerbate cyst progression in 
ADPKD.  
In conclusion, we have found that ouabain is a novel factor capable of 
stimulating the enlargement of ADPKD renal cysts.  Future research should be aimed 
to block ouabain-induced Na,K-ATPase signaling as a way to reduce cyst 
development and progression in the disease. 
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